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ABSTRACT 
Abuse is associated with higher depressive symptoms (DS) and coronary 
heart disease risk (CHD), lower health-related quality of life (HRQOL), and 
dysregulated levels of cortisol and norepinephrine (NE). In HIV+ women, abuse 
relates to higher viral load (VL), lower CD4 count, and nonadherence to highly 
active antiretroviral therapy (HAART). Resilience (adaptive functioning following 
trauma) and positive self-esteem (PSE) were hypothesized to buffer the impact 
of abuse and predict better health outcomes. Three studies tested these 
hypotheses using self-report measures (for abuse, resilience, DS, HRQOL, and 
HAART use and adherence), autobiographical narratives (for PSE), Framingham 
Risk Score (for CHD risk), and blood and urinary specimens for cortisol, NE, and 
HIV disease markers (VL and CD4 count).  
Study 1 included 138 HIV+ and 64 HIV- women (87% African-American), 
and investigated the relationships between childhood sexual abuse (CSA), DS, 
and HRQOL and whether resilience moderated the relationships between CSA 
and outcomes. Consistent with the hypothesis, multiple regressions indicated 
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that higher resilience related to lower DS and higher HRQOL across both HIV+ 
and HIV-women, and CSA related to higher DS only for women scoring low in 
resilience. 
Study 2 examined how resilience moderated the relationships between 
abuse history and HAART adherence, VL, and CD4 count in 138 HIV+ women. 
As predicted, multiple regressions revealed that resilience related to having 
undetectable VL. Sexual and multiple abuse histories related to lower HAART 
adherence only for women scoring low in resilience. 
Study 3 with 53 HIV+ women investigated the relationships among 
resilience, PSE, abuse histories, NE, cortisol and CHD risk.  In partial support of 
hypotheses, partial correlations showed that higher resilience related to lower 
cortisol; higher PSE related to lower NE; higher NE/cortisol ratio related to higher 
CHD risk; histories of abuse related to higher CHD risk, and lower cortisol related 
to higher CHD risk.  
The findings suggest that resilience and PSE relate to better health 
outcomes for HIV+ and HIV- women, and levels of stress hormones in HIV+ 
women are related in complex ways to abuse, resilience, PSE, and CHD risk. 
Promoting resilience and PSE may help HIV+ and HIV- women achieve better 
health outcomes.  
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CHAPTER ONE 
General Introduction 
Each year an estimated 50,000 individuals are newly infected with HIV in 
the United States and over one million individuals are currently living with HIV 
(Centers for Disease Control and Prevention, 2013b). With access to highly 
active antiretroviral therapy (HAART) and proper treatment adherence, HIV is a 
chronic illness and no longer a death sentence (Antiretroviral Therapy Cohort, 
2008). Thus, it is important to explore the factors that may promote greater 
longevity and better health outcomes for persons infected with HIV.  
There is a high prevalence of trauma/abuse history among women with 
HIV and demographicallly similar women who are at risk for HIV infection.   A 
history of abuse is associated with negative health outcomes such as higher 
depressive symptoms, lower quality of life, HIV medication nonadherence, 
antiretroviral failure and increased risk for heart disease (Cohen et al., 2004; 
Machtinger, Haberer, Wilson, & Weiss, 2012; Machtinger, Wilson, Haberer, & 
Weiss, 2012; Midei, Matthews, Chang, & Bromberger, 2013; Wilson, 2010). 
Women may also be resilient in the face of trauma and function adaptively 
following histories of abuse, however the literature has focused on factors that 
place women “at risk” for HIV transmission/ contraction and poor health 
outcomes, and far less attention has been given to factors that may place women 
“at promise” for better outcomes. Limited research indicates that positive coping 
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such as meaning making minimizes HIV disease progression (G. Ironson & 
Hayward, 2008; G. Ironson, Stuetzle, & Fletcher, 2006).   
Researchers have hypothesized that stress hormones such as 
norepinephrine and cortisol may explain some of the association between 
psychological stress such as abuse and health outcomes (Schneiderman, 
Ironson, & Siegel, 2005). Norepinephrine (NE) and cortisol are stress hormones 
that play a key role in the body’s biological and behavioral response to stress and 
trauma and have shown significant association with heart disease and HIV 
disease progression markers (Cole, Kemeny, Fahey, Zack, & Naliboff, 2003; 
Cole et al., 2001; Fantidis et al., 2002; Otte, Neylan, Pipkin, Browner, & Whooley, 
2005). However, little is known about how NE and cortisol levels relate to either 
abuse histories or to positive psychosocial factors such as resilience and positive 
self-esteem (Rozanski & Kubzansky, 2005).  
Among HIV+ and sociodemograhically matched HIV- women who were 
primarily African Americans, a series of three studies focused on the important 
understudied factors of resilience and positive self-esteem subsequent to trauma.  
The primary aims were to investigate how resilience and positive self-esteem 
related to mental and physical health outcomes including depressive symptoms, 
health-related quality of life, highly active antiretroviral therapy (HAART) 
adherence, HIV disease markers (i.e. viral load (marker of disease burden as the 
number of HIV virus particles in the blood increases) and CD4+ T cell count (a 
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measure of immune response with lower CD4 cells indicating more 
immunosupression), coronary heart disease (CHD) risk, and stress hormone 
levels (i.e. norephinephrine and cortisol).  Study 1 investigated the relationships 
among childhood sexual abuse (CSA), depressive symptoms, and health-related 
quality of life in138 HIV+ and a demographically matched sample of 64 HIV- 
women.  Further, the study investigated whether resilience moderated the 
relationships between CSA and health outcomes. Study 2 focused solely on 138 
HIV+ women and examined how resilience moderated the relationships between 
abuse history and HAART adherence, viral load, and CD4 count. Study 3 also 
focused on HIV+ women and investigated the relationships among resilience, 
positive self-esteem, abuse histories, NE and cortisol levels and CHD risk in a 
sample of 53 HIV+ women.  Depressive symptoms were also assessed as a 
potential mediator of the relationships investigated in studies 2 and 3. The 
findings can potentially inform the development of intervention strategies that 
promote resilience and positive self esteem in women with and at risk for HIV, 
hopefully leading to better mental and physical health outcomes. 
Depressive Symptoms and Quality of Life in Women with HIV 
In comparison to the general population, the lifetime prevalence of 
depressive disorders is significantly higher in women with HIV (Dew, Becker, 
Sanchez, & Caldararo, 1997; Gala, Pergami, Catalan, & Durbano, 1993; Kessler, 
Chiu, Demler, Merikangas, & Walters, 2005; Ronald C. Kessler et al., 2005; 
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Rabkin, 1996; Regier et al., 1990). In addition, HIV+ women have higher rates of 
depression and lower quality of life than men and HIV- women (Ickovics et al., 
2001; M. S. Kaplan, Marks, & Mertens, 1997; Tate et al., 2003). Higher 
depressive symptoms are often related to lower quality of life (Jia, Uphold, Wu, 
Chen, & Duncan, 2005; Tate et al., 2003).  Among HIV infected persons, 
depressive symptoms have also been shown to mediate the impact of 
psychosocial factors on quality of life. For instance, Jia and colleagues (2005) 
reported that higher social support and more adaptive coping with HIV (e.g. 
managing the illness) related to lower depressive symptoms and better quality of 
life and that depressive symptoms significantly mediated the relationships of 
social support and coping with HIV with quality of life. 
 Depression is also significantly associated with medication 
nonadherence, greater decline in CD4+ cell counts, antiretroviral failure, 
increased mortality, nondisclosure of HIV status to sexual partners, and higher 
risky sexual behaviors in women with HIV (Armistead, Morse, Forehand, Morse, 
& Clark, 1999; Boarts, Sledjeski, Bogart, & Delahanty, 2006; Catz, Kelly, Bogart, 
Benotsch, & McAuliffe, 2000; Cook et al., 2004; Cunningham, Crystal, Bozzette, 
& Hays, 2005; Ickovics et al., 2001; Leserman et al., 2007). Depression is 
therefore closely linked to a woman’s ability to adhere to HIV medication and her 
HIV disease progression.  
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Medication Adherence and HIV Disease Markers   
Consistent adherence to prescribed HAART regimens is essential to good 
health outcomes, including HIV viral suppression, improved CD4 cell counts and 
decreased rates of morbidity and mortality (Garcia de Olalla et al., 2002; Palella 
et al., 1998; Paterson et al., 2000; Wood et al., 2004). According to Patterson 
and colleagues (2000), at least a 95% adherence rate is necessary to achieve 
viral suppression and an undetectable viral load.  However, in the United States, 
the mean adherence rate is approximately 71%, with most individuals adhering at 
suboptimal rates (Golin et al., 2002; Mannheimer, Friedland, Matts, Child, & 
Chesney, 2002). Howard et al. (2002) found that among predominantly minority 
women the mean adherence rate ranged between 45% and 64% over time. 
Medication nonadherence can have serious consequences, such as the 
development of drug resistant strains of HIV, and therefore remains a major 
public health issue (Lucas, 2005; Richman et al., 2004; Wainberg & Friedland, 
1998).  
A growing body of literature exists on the factors that relate to 
nonadherence, however there is only a small body of literature on psychological 
factors that facilitate adherence. Factors that relate to nonadherence include 
trauma/abuse histories, depression, post-traumatic stress disorder (PTSD), low 
self-efficacy, parental responsibilities, partner relationship difficulties, perceived 
stigma, drug/alcohol use, low education literacy, and non-adaptive coping such 
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as denial and avoidance (Edwards, 2006; Howard et al., 2002; Kalichman, 
Ramachandran, & Catz, 1999; Murphy, Greenwell, & Hoffman, 2002; 
Vyavaharkar et al., 2007). Conversely, the factors that promote adherence 
include social support, positive states of mind, low negative affect, spirituality, 
self-efficacy, and good patient-physician relationships (Edwards, 2006; Roberts, 
2002; Simoni, Frick, & Huang, 2006; Sontag & Richardson, 1997; Vyavaharkar et 
al., 2007). 
HIV and Coronary Heart Disease  
In the era of HAART and with optimal adherence, HIV+ individuals are 
dying less from HIV related causes and are increasingly dying from non-HIV 
related causes such as heart disease. Coronary heart disease, (buildup of plaque 
inside the coronary arteries), is the most common type of heart disease (Go et 
al., 2013). HIV may put patients at higher risk for coronary heart disease.  For 
younger age groups, it may in part be linked to taking antiretroviral treatments 
(ART), which may increase CHD risk (Barbaro, 2003; Currier et al., 2003). Other 
risk factors for heart disease include genetics, diet, hypertension, diabetes, 
cigarette smoking and other environmental factors (de Lorgeril et al., 1994; 
Marenberg, Risch, Berkman, Floderus, & de Faire, 1994; O'Toole, Conklin, & 
Bhatnagar, 2008; P. W. Wilson et al., 1998). 
In addition, the majority of individuals infected with HIV are ethnic 
minorities from low socioeconomic backgrounds who experience daily stressors 
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such as discrimination and unstable neighborhoods that may place them at 
increased risk for CHD (Bennett et al., 2004;  Kaplan et al., 2007; Krantz & 
McCeney, 2002). Black Americans have the highest mortality due to 
cardiovascular disease when compared with other racial/ethnic groups. In 2009, 
19,270 Black women ages 20 and older died from CHD; and the age adjusted 
death rate for CHD was 110.3 for Black women compared to 84.9 for white 
women (Go et al., 2013). More recently, researchers have begun to note a 
connection between abuse histories and increased risk for heart disease across 
ethnic groups (Dong et al., 2004; Midei et al., 2013). In addition, literature exists 
that link dysregulated levels of stress hormones to heart disease risk (Fantidis et 
al., 2002; Otte et al., 2005). 	  
Stress Hormones  
 Cortisol (a corticosteroid) and NE (a catecholamine) are stress hormones 
that act as neurotransmitters in the central nervous system and sympathetic 
nervous system (Heritage, 2007). Stressors such as traumatic events lead to the 
release of NE and cortisol (among other hormones), which underlies the fight-
flight-freeze response. The baseline levels of cortisol and norepinephrine that an 
individual has as well as the levels released in response to stress are also 
impacted by genetics (Hu, Caron, & Sieber-Blum, 2009; Kohli et al., 2011; 
Velders et al., 2011; Wust, Federenko, Hellhammer, & Kirschbaum, 2000). When 
released under stressful conditions, NE and cortisol prepare the body to cope 
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with stress by increasing heart rate, triggering the release of glucose from energy 
stores, increasing blood flow to skeletal muscle, and decreasing digestion 
(Jonas, 2005). Due to their role in stress response, cortisol and NE have been 
key hormones investigated by researchers exploring the pathophysiology of 
stress.  
 Investigators have used various approaches to measure stress hormones. 
For instance hormones can be assessed from saliva, urinary collection, and 
blood plasma (Fantidis et al., 2002; Ironson et al., 2008; Vedhara, Tuinstra, 
Miles, Sanderman, & Ranchor, 2006). In addition, collection methods vary if done 
at a single time point, multiple time points, or over the course of several hours or 
days (Brand, 1999; Vedhara et al., 2006). Some investigators might be interested 
in the total hormone output, how the hormone levels differ/change between 
different time points (e.g. awakening response, which is the change between 
morning waking level and 15-60 min later), and/or the regression slope 
generated by hormone output at several time points over the course of one or 
more days (Fantidis et al., 2002; Ironson et al., 2008; Vedhara et al., 2006). For 
daily hormone patterns researchers expect to see a peak at early morning and 
decline over the course of the day. Thus, normal regression slope values are 
negative and further away from zero while abnormal slopes are flat with values 
closer to zero (Vedhara et al., 2006). 
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 While initial activation of the hypothalamic pituitary axis (HPA) in the face 
of trauma is adaptive and can help an individual survive a traumatic encounter 
(e.g. provide energy to muscles to escape), chronic arousal of the HPA in the 
form of high levels of cortisol and NE has been linked to anxiety, hyperarousal, 
heart disease and impaired immune functioning, while low levels of cortisol 
and/or NE have been associated with depression, irritability, hypotension, and 
attention-deficit hyperactivity disorder (Bennett et al., 2004; Girod & Brotman, 
2004; Knight, Avery, Janssen, & Powell, 2010; Oldenburg et al., 2001; Otte et al., 
2005; Velders et al., 2011; Viggiano, Ruocco, Arcieri, & Sadile, 2004; 
Vogelzangs et al., 2010). Thus, sustained elevated levels, extremely low levels or 
a blunted response (lack of response) of cortisol and NE are signs of 
dysregulation (Fantidis et al., 2002; Otte, McCaffery, Ali, & Whooley, 2007; 
Vedhara et al., 2006).  
  Researchers have noted that histories of abuse are linked with both high 
and low stress hormone levels. For instance Yehuda (2001) found that among 
adult offspring of Holocaust survivors, childhood emotional abuse was 
significantly associated with lower urinary cortisol. Lemieux and Cole (1995) 
reported higher overall 24-hour urinary cortisol and norepinephrine levels in 
women with a history of childhood sexual abuse and PTSD, but Bremner and 
colleagues (2003) found that women with a history of childhood sexual abuse 
and PTSD had lower levels of cortisol, but only during the afternoon hours (12-
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8pm) of a 24-hour urine collection. Further, Friedman et al. (2007) reported that 
among women who had histories of childhood sexual abuse, those with 
subsequent adult sexual abuse had higher 24-hour urinary norepinephrine and 
cortisol levels in comparison to those who were not revictimized. Inconsistencies 
are also displayed in the child literature with one study conducted among children 
finding that childhood neglect was associated with lower cortisol levels and flatter 
diurnal cortisol slopes, but childhood abuse (mostly physical) was associated 
with higher cortisol levels and steeper diurnal cortisol slopes (van der Vegt, van 
der Ende, Kirschbaum, Verhulst, & Tiemeier, 2009).  A study reported that a 
combination of high NE and low cortisol (i.e., high NE/cortisol ratio) may be 
especially sensitive in detecting individuals with a PTSD diagnosis who have 
been found to have higher NE/cortisol ratios than those without (Mason, Giller, 
Kosten, & Harkness, 1988).  However this study was conducted among male 
veterans and the findings were not replicated among women with PTSD 
(Lemieux & Coe, 1995). The inconsistencies in the literature may be due to time 
of day that urine/saliva is collected, the length of the collection period, what the 
situational context is that surrounds the collection and the age, ethnicity and 
gender of participants. For example, a study by Merritt et al (2011) found the 
African American caregivers showed flatter cortisol slope scores than White 
caregivers, which the authors suggests might be linked to additional stressors 
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(e.g. discrimination) experienced by African Americans as well as worse pre-
existing health factors. 
  Among patients with heart disease, higher levels of both NE and cortisol 
have been linked to increased risk of mortality and worse outcomes (Cohn et al., 
1984; Otte et al., 2007; Smith et al., 2005; Vogelzangs et al., 2010). However, 
cortisol and norepinephrine have anti-inflammatory properties and high levels 
have also been found to be beneficial for patients with coronary heart disease 
(Fantidis et al., 2002; Straub et al., 2002); and low levels of cortisol have also 
been linked to cardiovascular disease risk (Bennett et al., 2004).  These 
inconsistencies in relationships between stress hormones and CHD risk mirror 
those found in relationships between stress hormones and abuse and are not 
well understood in the literature. 
Abuse, HIV, and Health Outcomes 
Over 67% of 2000 HIV+ and 500 HIV- participants in the Women’s 
Interagency HIV Study (WIHS), reported histories of physical, sexual or 
emotional abuse (Cohen et al., 2000; Cohen et al., 2004). Similarly, in a meta-
analysis of HIV+ women, Machtinger and colleagues (2012) reported a 55.3% 
rate of intimate partner violence that is more than double the US national 
average and estimated a 30% rate of recent PTSD that is over five-times the rate 
in a national sample. Sachs-Ericsson et al (2005) found that individuals with a 
history of CSA had 1.5 greater likelihood of experiencing serious health problems 
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and George (1996) found that survivors of abuse were two times more likely to 
have mental health disorders than people without a history of abuse. 
Given such high rates of abuse HIV+ women are susceptible to negative 
consequences of abuse such as depression, substance abuse, eating disorders, 
obesity and autoimmune disorders (George, 1996; Pine, Goldstein, Wolk, & 
Weissman, 2001; Romans, Gendall, Martin, & Mullen, 2001; Sachs-Ericsson, 
Blazer, Plant, & Arnow, 2005; D. R. Wilson, 2010).  Histories of abuse have 
indeed been found to relate to negative health outcomes for HIV+ women, 
including HIV medication nonadherence, antiretroviral failure, and increased 
mortality (Cohen et al., 2000; Cohen et al., 2004; Leserman, Pence, & Stangl, 
2007; Machtinger et al., 2012; Meade et al., 2009).  For instance, Machtinger and 
colleagues (2012) found that among HIV+ biological and transgender women, 
those who reported recent trauma, including being threatened, abused, and the 
victim of violence had over four-times the odds of antiretroviral failure in 
comparison to HIV+ women who did not report recent trauma. Several noted 
consequences of abuse (e.g. obesity and substance use) are risk factors for 
heart disease and a limited number of studies have directly linked abuse histories 
to heart disease (Dong et al., 2004; Midei et al., 2013). It is also likely that 
because of their abuse histories along with psychosocial stressors of HIV 
infection itself, women with HIV may have dysregulated levels of stress 
hormones ( Cole, Kemeny, Fahey, Zack, & Naliboff, 2003; Friedman et al., 2007). 
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Resilience 
Resilience is the ability to function and cope adaptively in the face of or 
following adversities such as trauma and abuse (Connor and Davidson, 2003; 
Masten, Best, & Garmezy, 1990). Evidence exists to suggest that interactions 
among genetics, other biological processes, and the environment may lay the 
foundation for resilience (Caspi et al., 2003; Charney, 2004; Tannenbaum & 
Anisman, 2003; Waaktaar & Torgersen, 2012; Young, Gallagher, & Porter, 
2002). For instance, Caspi et al (2003) found that the 5-HTT gene promoter 
polymorphism moderated the relationship between stressful life events and 
depression and suicidality, such that individuals who were homozygous for the 
long allele of the gene had lower depressive symptoms, less diagnosable 
depression and lower suicidality in comparison with individuals who had one or 
two copies of the short allele of the gene. In addition, Weber and colleagues 
(2009) reported that the MAOA genotype moderated the relationship between 
childhood trauma exposure and aggressive behaviors so that high activity MAOA 
gene predicted lower aggressive scores in comparison to low activity MAOA 
gene. However, this moderation existed only in the context of low to moderate 
trauma exposure, but when trauma exposure was severe or extreme children 
had high aggressive scores regardless of MAOA genotype.   
 Environmental factors including close friendships, parental support, and 
strong family network are also associated with resilient functioning (Haskett, 
	  	  
	  
	  
14 
Nears, Ward, & McPherson, 2006; Wells, 2009). In addition, resilience has been 
linked to environmental and psychosocial resources such as higher education, 
higher income and employment although not consistently (Bonanno, Galea, 
Bucciarelli, & Vlahov, 2006, 2007; Dale et al.; Kjellstrand & Harper, 2012).   
In previous literature, scholars have defined and studied resilience as the 
process of bouncing back from an adversity, (Jacelon, 1997; Olsson, Bond, 
Burns, Vella-Brodrick, & Sawyer, 2003), an outcome consisting of adaptive 
functioning (Bonanno, 2012; Bonanno et al., 2006), and/or a set of personality 
traits (Connor & Davidson, 2003; Jacelon, 1997). Researchers who view 
resilience as a process emphasize “how” someone adapts successfully following 
trauma (Fine, 1991; Jacelon, 1997; Luthar & Cicchetti, 2000). For instance, Fine 
(1991) described a two stage resilience process that included: (1) acute phase: 
individual focuses their energy on managing and minimizing the impact of the 
stressor and (2) reorganization phase: accepting and facing their new realities.          
In contrast, some researchers view resilience as an outcome, but there 
are many variations in the particular outcome representing resilience (e.g. 
improved mental health status or symptomology, reduction in substance use). 
McGeary (2011), in a review of 25 randomly selected peer reviewed articles on 
resilience, noted that 13 different measures of resilience outcome were noted 
such as physical functioning and behaviors. Furthermore, researchers such as 
Bonanno (2012, p. 753) encourage the conceptualization of resilience as an 
	  	  
	  
	  
15 
outcome trajectory and defined resilience as “a stable trajectory of healthy 
functioning in response to a clearly defined event.”  
Others view resilience not as a process or outcome, but as personality 
traits or qualities that might facilitate the process of bouncing back or arriving at a 
good outcome. Wagnild and Young (1993, p. 165) defined resilience as “a 
personality characteristic that moderates the negative effects of stress and 
promotes adaption” and similarly Connor and Davidson (2003, p. 76) wrote 
“resilience embodies the personal qualities that enable one to thrive in the face of 
adversity.” Researchers who view resilience as personal qualities posit that these 
include characteristics such as commitment, sense of humor, optimism, self-
efficacy, having a realistic sense of control, being action and goal-oriented, 
viewing stress as a challenge/opportunity, and being able to adapt to change 
(Connor & Davidson, 2003; Kobasa, 1979; Lyons, 1991; Rutter, 1985; Werner, 
2004; Werner, 1993). In addition, self-esteem is a factor that relates to resilience.  
Self-esteem consists of the views, beliefs, and emotions people hold about 
themselves that can range from negative to positive, and can be with respect to 
abilities, personality traits, and accomplishments (Mruk, 2006). Positive self-
esteem has been associated with resilience (Dumont & Provost, 1999) and has 
been noted as a factor that promotes resilience among individuals who 
experience adversity and high-risk environments (Werner, 2004). Self-esteem is 
also impacted by resilience, in that an individual who strives in the face of 
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hardship may feel positive about herself based on this experience (Baumeister, 
Campbell, Krueger, & Vohs, 2003). 
In summary there are many ways of conceptualizing and measuring 
resilience, but in general it is assumed to be the ability to function adaptively 
following a traumatic experience, which may involve personality characteristics, 
coping strategies, and/or outcomes.  It is also probable that positive adaptation is 
a process that occurs over time.  Further both genetics and psychosocial 
experiences are assumed to contribute to resilience.  
Resilience, Black Women, and HIV 
Resilience is especially important in the lives of women with HIV who are 
faced with multiple stressors. In the United States Black women represent the 
largest proportion of women who are newly diagnosed and/or living with HIV 
(Centers for Disease Control and Prevention, 2013b) and they face stressors 
such as HIV related stigma, interpersonal violence, child-rearing responsibilities, 
mental illness, poverty, unstable environments, microaggressions, racial/ gender 
discrimination and systemic exclusion from resources/opportunities, such as 
access to quality health care, education and employment (Centers for Disease 
Control and Prevention, 2013a, 2013b; Cohen et al., 2000; DeMarco, Miller, 
Patsdaughter, Chisholm, & Grindel, 1998; Ingram & Hutchinson, 1999; Kelso, 
2013). As such, it is especially important to investigate resilience and how it 
relates to health outcomes in samples of Black women with HIV because women 
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who are resilient may be able to thrive despite these circumstances and engage 
in healthy behaviors such as adhering to medication and establishing fulfilling 
lives. 
Within the past decade scholars have noted that Black women show high 
levels of resilience despite their adverse circumstances and experiences 
(Caldwell-Colbert, Parks, & Eshun, 2009; Dale et al.; O’Connor, 2002; Singleton, 
2004). Their coping strategies that are associated with resilience, including an 
internal locus of control, belief in a divine order, the presence of strong female 
role models, the capacity for forgiveness, and lower perceived stress (Faison, 
2007; Norman, 2002; Singleton, 2004). However, most of the studies on 
resilience among Black women have been based on qualitative inquiry rather 
than on a quantitative resilience measure, and among Black women and women 
with HIV, few studies have investigated the link between resilience (measured 
quantitatively) and health outcomes such as depression, quality of life, HIV 
medication adherence, HIV disease markers and CHD risk (Faison, 2007; 
Norman, 2002; Singleton, 2004).   
 
 
Resilience and Health Outcomes 
In the general population resilience has been linked to good health 
outcomes including less depression, fewer psychiatric symptoms, higher quality 
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of life, and positive response to psychopharmacology treatments (Campbell-Sills 
& Stein, 2007; Davidson et al., 2012).  Measures of resilience in these studies 
have included a widely used self-report resilience measure the Connor-Davidson 
Resilience Scale (CD-RISC) and other self-report questionnaires. For instance, in 
patients diagnosed with PTSD or depression, higher pretreatment resilience 
scores on the CD-RISC predicted better response to treatment with 
antidepressants (Davidson et al., 2012; Min, Lee, Lee, Lee, & Chae, 2012). 
Similarly, in a sample of women with infertility problems higher resilience (as 
measured by the CD-RISC) was associated with lower fertility related and 
general distress (Sexton, Byrd, & von Kluge, 2010).  
Resilience has been shown to mitigate or buffer the impact of adverse 
experiences on health. Among returning soldiers who served in Operation Iraqi 
Freedom and Operation Enduring Freedom, resilience (using the CD-RISC) was 
found to be protective against depressive symptoms and traumatic stress 
(Pietrzak, Johnson, Goldstein, Malley, & Southwick, 2009) and a longitudinal 
study found that higher resilience (a factor score comprised of scales measuring 
self-esteem, self-efficacy, self-mastery and optimism) buffered against 
worsening diabetes health markers (Yi, Vitaliano, Smith, Yi, & Weinger, 2008).  
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Resilience, Depression, and Quality of Life in Persons with HIV 
While studies among community samples have shown that higher 
resilience relates to lower depression and other psychiatric symptoms (Campbell-
Sills & Stein, 2007; Davidson et al., 2012; Sexton, Byrd, & von Kluge, 2010), 
among HIV infected individuals only a small number of studies have explored 
these relationships (Farber, Schwartz, Schaper, Moonen, & McDaniel, 2000; 
Scali et al., 2012; Wingo et al., 2010; Yu et al., 2009a). In a sample of individuals 
with symptomatic HIV and AIDS in the U.S., higher hardiness (a construct closely 
related to resilience which often assumes some protective personality 
characteristics prior to experiencing the adversity and is measured with the 
Dispositional Resilience Scale) was significantly related to higher physical health 
quality of life and lower psychological distress (Farber et al., 2000). Similarly, 
among individuals with HIV in rural China, Yu and colleagues (2009a) found that 
higher resilience (using the CD-RISC), was associated with lower depression.  
Some literature suggests that resilience can moderate the relationship 
between abuse and depression. In a community sample Wingo and colleagues 
(2010) found that childhood abuse and trauma exposure were related to higher 
depression severity, and that resilience, as measured with the CD-RISC 10-item, 
moderated the relationships between trauma and depression scores such that 
the high resilience group had lower depression scores than the medium and low 
resilience groups.  
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Resilience, Medication Adherence, and HIV Disease Markers  
 While no studies to our knowledge have reported a link between resilience 
and HIV medication adherence or disease markers, some studies have indicated 
that positive coping strategies are related to better antiretroviral therapy (ART) 
adherence and HIV disease markers (Ickovics et al., 2006; O'Cleirigh, Ironson, 
Weiss, & Costa, 2007).  The relationship between positive coping strategies and 
better HAART adherence is critical because HAART adherence relates to better 
HIV biomarkers, including viral load and CD4 + cell count.  Among HIV infected 
women, Ickovics et al. (2006) found that adaptive psychological coping 
strategies, including positive affect, positive expectancy regarding health 
outcomes, and finding meaning in challenging circumstances, were negatively 
associated with HIV mortality, time to death, and CD4+ cell count decline. In 
addition, over a one year period, conscientiousness  (e.g., being organized, detail 
oriented and responsible) was associated positively with medication adherence 
and at the one-year point conscientiousness predicted decreases in viral load 
and increases in CD4 count (O'Cleirigh et al., 2007).  Because resilience (as 
measured with the CD-RISC) is conceptualized as both adaptive personality 
traits and coping strategies (e.g. optimism), it has the potential to relate to better 
medication adherence and HIV disease markers.  For example, resilient women 
may be optimistic about living longer and may view maintaining their health as a 
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goal to work towards and consequently adhere to their medications, which would 
result in better HIV disease markers, including undetectable viral load and higher 
CD4 counts.  
 Resilience, Stress Hormones, and CHD risk  
 There are very few studies that have looked at the relationship between 
resilience and stress hormones. In a sample of maltreated and nonmaltreated 
children, Cicchetti and Rogosch (2007) found that higher psychological resilience 
(measured as a composite of self-report and observer ratings on aspects 
including social functioning, behavioral ratings, and depressive symptoms ) was 
associated with lower morning cortisol levels in nonmaltreated children, and with 
higher cortisol levels in physically abused children. Thus, higher resilience, 
measured in a variety of ways, has been associated with lower and higher levels 
of stress hormones.  
 Few studies have looked at resilience (or hardiness) and stress hormones in 
relation to heart disease risk or among patients with heart disease. Risk factors 
for CHD include high blood pressure, low “good” cholesterol, and high “bad” 
cholesterol and two studies have linked these factors to low resilience. Kasi and 
Cobb (1995) reported that men whose blood pressure remained higher longer 
were lower on ego resilience, reported longer lasting subjective stress and more 
severe unemployment. Ego resilience was defined as the ability to modify one’s 
inhibition/expression of impulses based on context and environmental factors 
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and measured by the Ego Resilience Scale (Block & Block, 1980).  Further, 
Bartone et al. (2009) found that psychological hardiness (measured with the 
Dispositional Resilience Scale) was associated with increased levels of  high 
density lipoprotein (HDL) cholesterol (good cholesterol), and there was a non-
significant negative association with low density lipoprotein (LDL) cholesterol 
(bad cholesterol). Having heart disease and risk for subsequent attacks have 
also been linked to resilience. Patients with coronary heart disease were found to 
experience more stress and to have lower hardiness (measured with a composite 
score from questionnaires thought to capture commitment, control, and 
challenge) compared to a group without coronary heart disease (Bayazi & 
Rastegari, 2005). In addition, Affleck et al. found that heart attack patients who 
engaged in meaning making, a coping strategy related to resilience,  
(incorporating negative events into belief systems and regaining a positive view 
of the world) and who perceived benefits from their first attack were less likely to 
have a subsequent attack and exhibited less morbidity over an 8-year follow-up 
(1987).  
 Although there is little literature on the relationships between resilience and 
CHD risk, a few studies suggest that lower resilience may significantly relate to 
higher CHD risk. These inconsistencies between resilience and stress hormones 
mirror the inconsistencies found in the relationships of stress hormones with both 
abuse histories and CHD risk.  
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Self-esteem in Relation to Stress Hormones, and CHD Risk  
Positive self-esteem (SE) is a factor that facilitates resilience and as such 
may also relate to stress hormones and lower CHD risk, however the literature in 
this area is limited. Higher self-esteem has been associated with lower levels of 
cortisol, and self-esteem was found to moderate the relationship between cortisol 
reactivity and depressed mood so that for the high SE group increased cortisol 
levels significantly predicted depressed mood, but for the low SE group 
decreased cortisol levels approached significance in predicting depressed mood 
(Pruessner, Lord, Meaney, & Lupien, 2004; Scarpa & Luscher, 2002; Seeman et 
al., 1995). We are unaware of any studies that investigated bidirectional 
relationships between self-esteem and heart disease risk among adults. 
However, in a sample of adolescents with heart disease, researchers found that 
in comparison to adolescents with mild heart disease, adolescents with severe 
heart disease reported lower self esteem (Cohen, Mansoor, Langut, & Lorber, 
2007). Wray and Sensky (1998) also noted an increase in self-esteem following 
heart surgery in children and adolescents. However, it’s not clear what the cause 
and effect are in this relationship: it may be that having heart disease leads to 
lower self-esteem because of the physical limitations imposed and/or that having 
lower self esteem makes heart disease more likely by affecting other related risk 
factors such as diet and exercise (Sorensen, Anderssen, Hjerman, Holme, & 
Ursin, 1999).  
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Depressive Symptoms, Positive Self-esteem, Stress Hormones, and CHD 
Risk 
Depressive symptoms have been linked to low and negative self-esteem 
as well as to dysregulated levels of stress hormones and increased risk for CHD. 
The Diagnostic and Statistical Manual (DSM-IV TR) recognizes negative self-
evaluations (i.e. feelings of worthlessness) as one of the symptom criteria for the 
diagnosis of depression and individual studies have also validated relationships 
between low self-esteem and higher depressive symptoms. For instance, Kernis 
and colleagues (Kernis, Grannemann, & Mathis, 1991) found that lower self-
esteem was associated with higher depressive symptoms among male and 
female college undergraduates. Similarly Orth and colleagues (Orth, Robins, & 
Roberts, 2008) in a longitudinal study found that lower self-esteem predicted 
subsequent levels of higher depressive symptoms among men and women.  
In addition to being linked with self-esteem, depressive symptoms have 
also been associated with dysregulated levels of norepinephrine and cortisol, 
although the direction has been somewhat inconsistent. Among middle-aged 
women researchers found that higher levels of depressive symptoms were 
associated with higher 24-hour urinary norepinephrine and cortisol levels 
(Hughes, Watkins, Blumenthal, Kuhn, & Sherwood, 2004) and among patients 
with coronary heart disease those with depressive symptoms had higher 
norepinephrine levels than those without depressive symptoms (Otte et al., 
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2005). In contrast, some studies have found significant associations between 
higher depressive symptoms and lower levels of cortisol, flat cortisol slope, and a 
blunted cortisol response (Burke, Fernald, Gertler, & Adler, 2005; Knight et al., 
2010). Further a study by Bremmer and colleagues (2007) suggested that among 
older patients the relationship between depression and cortisol is u-shaped, with 
both high cortisol and low cortisol found among patients with depression.  
Perhaps due in part to their connection with stress hormone levels, 
depressive symptoms have often been associated with increased risk for CHD 
(Khawaja, Westermeyer, Gajwani, & Feinstein, 2009). For instance, a study 
found that among women, depressive symptoms were associated with CHD 
incidence and risk for CHD mortality (Mendes de Leon et al., 1998). Depression 
may also partially be linked to increased risk for CHD as a result of unhealthy diet 
and lifestyle practices (e.g. lack of exercise) noted among individuals with 
depression (Gallagher, Zelestis, Hollams, Denney-Wilson, & Kirkness, 2013). 
Given that higher depressive symptoms have been related to low self-esteem, 
dysregulated levels of stress hormones, and increased risk for CHD, depressive 
symptoms may be a potential mediator of relationships among other variables of 
interest, such as the relationship between positive self-esteem and stress 
hormones.   
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Summary and Present Studies 
 In summary, the existing literature highlights that high prevalence of abuse 
histories in women with HIV have been linked to higher depression, lower quality 
of life, medication nonadherence, HIV mortality, and increased risk for CHD.  
Higher depression, lower quality of life, and increased CHD risk are more apt to 
be associated with women with HIV who have been abused in comparison to 
both non-abused women with HIV and HIV- women.  The relationships between 
abuse and poor health outcomes may be mediated or moderated by stress 
hormone levels. There is literature to suggest that resilience and positive self-
esteem may relate to better health outcomes for women who have been abused 
and for women with and at risk for HIV, perhaps by affecting stress hormone 
levels.  Resilience and positive self-esteem may potentially buffer the untoward 
impact of abuse on health outcomes as mediated by stress hormone levels. In 
addition, depressive symptoms have been related to HAART nonadherence, HIV 
disease markers, stress hormones and CHD risk and may be a potential 
mediator of the relationships that resilience and positive self-esteem have with 
these variables. 
 Three studies were designed to investigate the relationships among abuse 
histories, resilience, positive self-esteem and noted health outcomes among 
HIV+ and HIV- sociodemographically similar women. Study 1 investigates the 
relationships among CSA, resilience, depressive symptoms and health-related 
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quality of life among HIV+ and HIV- women and whether the relationships 
between CSA, depressive symptoms, and health-related quality of life were 
moderated by resilience.  In a sample of women with HIV, study 2 investigates 
whether resilience related to HIV health outcomes (i.e. detectable viral load and 
CD4+ cell count) and HAART adherence and whether these relationships were 
mediated by depressive symptoms and if resilience moderated the relationships 
of abuse history with HIV medication adherence and HIV biomarkers. Study 3 
investigates the relationships among resilience, positive self-esteem, abuse 
histories, levels of stress hormones (i.e. norepinephrine and cortisol) and 
coronary heart disease (CHD) among women with HIV and whether depressive 
symptoms mediated these relationships. Findings from these three studies may 
inform prevention and intervention strategies to promote better health outcomes 
among women with HIV and demographically similar women at risk for HIV.  
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CHAPTER TWO 
Study #1: Resilience, Childhood Sexual Abuse, Depressive symptoms,  
    and Health-Related Quality of Life in Women with and at Risk for HIV 
Introduction 
The present study sought to contribute to the literature by investigating the 
relationships among childhood sexual abuse (CSA), resilience, depressive 
symptoms and health related quality of life among women infected with HIV and 
a demographically matched sample of uninfected women. Previous literature has 
indicated that CSA is related to depression and poor quality of life for adult 
survivors (Draper et al., 2008; Irish, Kobayashi, & Delahanty, 2010). However, 
women who are resilient (with adaptive personal qualities and coping strategies) 
may have lower depressive symptoms and higher quality of life as suggested by 
studies among community samples (Campbell-Sills & Stein, 2007; Davidson et 
al., 2012; Sexton et al., 2010).  Limited literature also suggests that resilience 
can moderate the relationship between CSA and depressive symptoms (Kelsch, 
2012; Wingo et al., 2010).  Only a limited number of studies have investigated 
relationships among resilience, depressive symptoms, and quality of life among 
HIV infected individuals (Farber et al., 2000; Scali et al., 2012; Wingo et al., 
2010; Yu et al., 2009a). Depressive symptoms and quality of life are very 
pertinent to the lives of women with HIV, with depressive symptoms linked to HIV 
medication nonadherence  and increased mortality (Ickovics et al., 2001; 
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Leserman et al., 2007) and with medication adherence affecting quality of life (Liu 
et al., 2006) and perhaps being affected by it as well.  
Consistent with and building upon previous literature, the present study 
hypothesized that: (1) HIV+ women would have higher depressive symptoms and 
lower quality of life than HIV- women, (2) CSA would relate to higher depressive 
symptoms and lower quality of life among all women, (3) higher resilience would 
relate to lower depressive symptoms and higher quality of life among all women 
and (4) resilience would moderate the relationships between CSA and 
depressive symptoms and CSA and quality of life among all women, such that for 
women scoring low in resilience, CSA would predict higher depressive symptoms 
and lower quality of life, but for women scoring high on resilience CSA would be 
unrelated to depressive symptoms and HRQOL. We also explored the HIV status 
differences in patterns of relationships of resilience with CSA, depressive 
symptoms and health related quality of life, but no specific hypotheses were 
formulated due to the lack of previous literature.  
Methods 
Sample, Recruitment and Procedures 
The sample consisted of 202 women (138 HIV+ and 64 HIV-) from three 
enrollment waves (wave 1 (1994-5), n= 48; wave 2 (2001) n= 87; wave 3 (2011) 
n= 67)) of the Chicago site of the Women's Interagency HIV Study (WIHS). The 
WIHS is a prospective cohort study that seeks to understand HIV disease 
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progression in women.  Cohort enrollment and characteristics at the six U.S. 
WIHS sites have previously been described (Bacon et al., 2005; Barkan et al., 
1998). Women in Chicago WIHS were approached at a visit between 2008 and 
2012 to participate in this study. Written informed consent was obtained and 
participants received a financial honorarium of $25 in support of their time and 
effort, transportation, and childcare as needed. The study protocol was approved 
by the Stroger and Boston University Institutional Review Boards and the WIHS 
Executive Committee.  
Measures  
To assess for a history of CSA, at baseline visit, women were asked 
whether they were sexually abused prior to age 18. Three self-report validated 
measures were used to capture resilience, depressive symptoms and health 
related quality of life as described below.  
Connor-Davidson Resilience Scale -10 item (Campbell-Sills & Stein, 
2007). The CD-RISC is a 10-item self-report measure with a 4-point Likert-type 
scale that assesses the individual’s ability to thrive despite adversity (Campbell-
Sills & Stein, 2007) using both personality traits and successful coping as 
indications of thriving. For instance, one item reads “Tend to bounce back after 
illness or hardship”. Total scores range from 0 to 40 with higher scores reflecting 
greater resilience. The CD-RISC has demonstrated good internal consistency 
(Cronbach’s α coefficient = .85) and construct validity was supported by CD-
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RISC score moderating the relationship between childhood maltreatment, trauma 
exposure, and psychiatric symptoms in the general population (Campbell-Sills & 
Stein, 2007). Consistent with previous literature, the Cronbach’s alpha reliability 
coefficient for the CD-RISC in the current sample was .91 and a principal 
components factor analysis yielded one factor with an eigenvalue over 1, 
accounting for 56% of the variance. 
Center for Epidemiological Studies Depression Scale (CES-D 
Scale)(Radloff, 1977). This is a 20-item, self-report measure of current, affective 
depressive symptoms that is widely used in studies of women with HIV. 
Participants rate their level of agreement with each item on a 4-point scale. The 
CES-D shows high internal consistency while test-retest reliability correlations 
are moderate. CES-D scores were found to significantly predict mortality and 
CD4+ cell counts in HIV infected women participating in the multisite prospective 
HIV Epidemiology Research Study (HERS) and women participating in the WIHS 
(French et al., 2009; Ickovics et al., 2001). Cronbach’s alpha reliability coefficient 
for the CES-D in the current sample was .98. 
Quality of Life (HRQOL). This is a short form of The Medical Outcome 
Study (MOS)-HIV, a widely used disease specific instrument for quality of life 
developed by Bozzette et al. (1995), and adapted for use in WIHS. The 
shortened form has 21 items representing 6 domains: physical functioning, role 
functioning, social functioning, pain, emotional well-being, and general health 
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perception. All reliability indices were between 0.78 and 0.85 (Bozzette, Hays, 
Berry, Kanouse, & Wu, 1995). Cronbach’s alphas are not typically calculated for 
the overall scale or for the two subscales (i.e. pain and social functioning 
subscales) with one or two items.  In the current sample Cronbach’s alpha 
reliability coefficients for the four subscales with more than two items ranged 
from .69 to .99. 
Statistical Analyses 
SPSS version 19.0 was used to analyze the data with Pearson 
correlations, partial correlations, and independent samples t-test, and 
hierarchical multiple linear regressions. Stata 11.0 was also used to run a 
meditational analysis for indirect effects. Four participants were missing data on 
childhood sexual abuse; one participant was missing one item on the CD-RISC; 
and 35 participants were missing HRQOL data because HRQOL was not 
collected at the resiliency study visit for those women, who were enrolled in the 
third enrollment wave of WIHS (2011) and for whom the study visit was their first 
visit. The one missing item on the CD-RISC was replaced with the respondent’s 
average item score computed from the mean of the nine completed items.  
Results 
Approximately 87% of the 202 women (138 HIV+ and 64 HIV-) self-
identified as African American, 62% completed at least high school, and 27% 
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reported a history of CSA. Table 1 displays the sample demographics and clinical 
characteristics.  
----------------------------------------------------- 
Insert Table 1 about here 
----------------------------------------------------- 
Preliminary Analyses 
As assessed by chi-square and t-tests HIV+ and HIV- women did not differ 
in race, age, education, enrollment wave, CSA history, and resilience, but HIV- 
women reported higher levels of income and were more likely to be employed 
than HIV+ women. Partial correlations in the entire sample controlling for HIV 
status showed that higher education, employment and higher income were 
significantly related to higher resilience, lower depressive symptoms and higher 
HRQOL, while being older was related to a lower HRQOL, as displayed in Table 
2. A history of CSA was significantly related to being older, enrolling during an 
earlier wave, and having higher education. Based on these findings, age, 
education, employment, income, and enrollment wave were included as 
covariates in all subsequent analyses.  
------------------------------------------------------- 
Insert Table 2 about here 
-------------------------------------------------------- 
Hypothesis 1:  HIV Status Differences in Depressive Symptoms and HRQOL 
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 To test the hypothesis that HIV+ women would have higher depressive 
symptoms and lower HRQOL than HIV- women, partial correlations with HIV 
status, depressive symptoms, and HRQOL were run controlling for age, 
education, employment, income, and enrollment wave. Results indicated that 
HIV+ women reported significantly lower HRQOL than HIV- women (r= -.21, 
p=.01), but the two groups did not differ in reported depressive symptoms (r= .02, 
p=ns). Thus, hypothesis 1 was partially confirmed.  
Exploratory Question: HIV Status as Moderator of Relationships between 
CSA, Resilience and Outcomes 
We were interested in investigating if the nature of the relationships 
among CSA, resilience, depressive symptoms and HRQOL differed based on 
HIV status and if resilience and HIV status moderated relationships of CSA with 
depression and quality of life. Regression analyses were conducted for three-way 
interactions with HIV status, CSA, and resilience, and two-way interactions 
between HIV status and resilience and HIV status and CSA. Covariates were 
income, education, employment, age and wave entered in block 1; main effects 
were HIV status, CSA and resilience entered as predictors in block 2; dummy 
variables representing the two-way interactions of HIV status with resilience, HIV 
status with CSA, and CSA with resilience were entered in block 3; and dummy 
variables representing the three-way interaction of HIV status, CSA, and 
resilience were entered in block 4.  The outcomes were depressive symptoms 
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and HRQOL scores.  Findings indicated that the three-way interaction between 
HIV status, CSA, and resilience, and the two-way interactions between HIV 
status and resilience and HIV status and CSA did not significantly relate to 
depressive symptoms and health related HRQOL.  
Given that HIV+ and HIV- women did not differ in sociodemographics, 
CSA, resilience, and depressive symptoms and the nature of the relationships 
between CSA, resilience, depressive symptoms and HRQOL did not differ based 
on HIV status, HIV+ and HIV- women were combined in further analyses and HIV 
status was included as a covariate.   
Hypothesis 2: Relationships of CSA with Depressive symptoms and 
HRQOL 
 Hierarchical multiple linear regressions were used to test the hypothesis 
that CSA would relate to higher depressive symptoms and lower quality of life 
while controlling for age, education, employment, income, HIV status, and wave. 
In the analyses, covariates were entered in block 1, CSA was entered as a main 
effect in block 2, and outcomes were HRQOL or depressive symptoms. CSA 
significantly related to lower HRQOL (β = -.18, t = -2.12, p = .04) and approached 
significance in relating to higher depressive symptoms (β = .12, t = 1.60, p = .11), 
indicating that women with a history of childhood sexual abuse reported lower 
health related HRQOL and tended to report higher depressive symptoms. Thus, 
hypothesis 3 was partially confirmed.  
	  	  
	  
	  
36 
Hypothesis 3: Relationships between Resilience, Depressive symptoms 
and HRQOL 
 To test the hypothesis that higher levels of resilience would relate to lower 
depressive symptoms and higher HRQOL we conducted multiple linear 
regressions while controlling for covariates of age, education, employment, 
income, HIV status, and wave. In block 1, covariates were entered, in block 2 
resilience was entered as a main effect, and the outcomes were depressive 
symptoms or HRQOL. Findings indicated that resilience was significantly 
negatively related to depressive symptoms (β = -.49, t = -7.98, p = .001) and 
significantly positively related to HRQOL (β = .27, t = 3.67, p = .001) so that 
higher resilience related to lower depressive symptoms and higher HRQOL Thus, 
hypothesis 3 was confirmed.  
 An additional regression analysis was conducted to explore the 
relationship between the two outcomes of depressive symptoms and HRQOL. In 
this regression covariates were entered in block 1, depressive symptoms were 
entered as the main effect in block 2, and HRQOL was the outcome; and results 
showed that higher depressive symptoms significantly related to lower HRQOL (β 
= -.44, t = -6.14, p = .001).   
 Although this was not an initial aim of this paper, given that resilience 
significantly related to both lower depressive symptoms and higher HRQOL a 
mediation analysis was conducted to investigate whether depressive symptoms 
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mediated the relationship between resilience and quality of life. Stata 11.0 was 
used to calculate the size of the direct and indirect effects and test for their 
significance with bootstrap. In the command, resilience was the predictor, 
HRQOL was the outcome, depressive symptoms were the mediator and 
covariates were income, education, employment, age, wave and HIV status. 
Results indicated that the direct effect from resilience to HRQOL was not 
significant (observed coefficient = .08, bias= .002, bootstrap standard of error = 
.09, bias corrected confidence interval (95%) =  -.09  - .25), but the indirect effect 
from resilience through depressive symptoms to HRQOL was significant 
(observed coefficient = .19, bias=  -.003, bootstrap standard of error =  .05, bias 
corrected confidence interval (95%) = .10  - .31), with depressive symptoms 
mediating 74% of the relationship between resilience and HRQOL. The total 
effect from resilience to HRQOL was also significant (observed coefficient = .27, 
bias=  -.001, bootstrap standard of error =  .08, bias corrected confidence interval 
(95%) = .13  - .41). These findings suggest that resilience impacts HRQOL 
through the compound pathways of resilience to depressive symptoms and 
depressive symptoms to HRQOL.  
Hypothesis 4: Resilience Moderating the Relationships between CSA, 
Depressive symptoms and HRQOL 
To test the hypothesis that resilience moderated the relationships between 
CSA and depressive symptoms and CSA and HRQOL, we conducted 
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hierarchical multiple linear regressions. Regression analyses included the 
covariates: income, education, employment, age, wave and status entered in 
block 1; the main effects CSA and resilience entered as predictors in block 2, and 
dummy variables representing the interaction of resilience with CSA entered in 
block 3.  The outcomes were depressive symptoms and HRQOL scores. Results 
showed that the interaction between resilience and CSA significantly related to 
depressive symptoms (β = -.16, t = -2.73, p = .007), but did not significantly relate 
to HRQOL (β = .01, t = .16, p = ns).  To interpret this finding using methods 
suggested by Holmbeck (1998, 2002) women’s resilience scores were divided 
into low (1 SD below mean, N=38) and high (1 SD above mean, N=43) resilience 
groups and regressions were run separately for each group with covariates 
entered in block 1, CSA as the main effect in block 2, and depressive symptoms 
as the outcome. The nature of the relationship between resilience and 
depressive symptoms differed based on level of resilience, in that CSA 
significantly related to higher depressive symptoms only for women scoring low 
in resilience (β = .32, t = 2.15, p = .04, n=38) but not for women high in resilience 
(β = -.001, t = -.01, p = ns, n=40), as displayed in Figure 1.  
------------------------------------------------------- 
Insert Figure 1 about here 
-------------------------------------------------------- 
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Discussion  
As hypothesized, women with HIV reported significantly lower health 
related quality of life than uninfected women. This is consistent with previous 
literature and with the additional health burden HIV infected women face from 
living with HIV (Ingram & Hutchinson, 1999)(Liu et al., 2006; McDonnell et al., 
2005)(Brody, 2013). However, contrary to hypotheses, we did not find a significant 
difference in depressive symptoms scores between HIV infected and uninfected 
women. The HIV+ and HIV- women in our sample are sociodemographically 
similar and experience similar vulnerabilities and stressors such as low 
socioeconomic status and unemployment (Bacon et al., 2005), which may partly 
explain the lack of difference in depressive symptoms by HIV status. It is also 
noteworthy that the majority of the current sample has been participating in a 
longitudinal study for years, and as such these women may have developed 
support networks and access to resources that reduced the disparity in 
depressive scores between HIV infected and uninfected women.  
 Consistent with prior literature and with hypotheses, we found that women 
with a history of childhood sexual abuse reported lower health related quality of 
life. Childhood sexual abuse also approached significance in relating to higher 
depressive symptoms in our sample, and although non-significant, this trend is 
consistent with the literature noting that CSA relates to higher depressive 
symptoms in adulthood (Sachs-Ericsson et al., 2005).  Perhaps we were limited 
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by our sample size in detecting significant relationships between CSA and 
depressive symptoms. In addition, women in our sample who did not report CSA 
may have been exposed to other forms of childhood/adult trauma and 
environmental stressors, such as racial and gender discrimination (Bacon et al., 
2005; Kelso, 2013) that may account for the lack of difference in depressive 
symptoms between women with a history of CSA and those without.  
Also as hypothesized, we found that higher resilience significantly related 
to lower depressive symptoms and health related quality of life in our sample of 
HIV infected and uninfected women. Higher resilience relating to lower 
depressive symptoms and better health related quality of life is consistent with 
two previous studies among HIV infected individuals that found that lower 
resilience was associated with higher depressive symptoms and that hardiness 
(a construct similar to resilience) was related to lower psychological distress and 
higher physical health quality of life (Farber et al., 2000; Yu et al., 2009a).  
Our post-hoc analysis showing that depressive symptoms mediated the 
relationship between resilience and quality of life suggest that interventions 
aimed at increasing resilience and lowering depressive symptoms among HIV 
infected and uninfected women may improve quality of life. Given that depressive 
symptoms and quality of life have been linked to other negative health outcomes 
among HIV infected women such as disease progression and medication non-
adherence (Cook et al., 2002; Dew et al., 1997) interventions which increase 
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resilience among HIV infected and uninfected women may lead to lower 
depressive symptoms and better health related quality of life as well as other 
related health outcomes. 
One of the most important findings from our analysis is that resilience 
moderated the relationship between CSA and higher depressive symptoms as 
hypothesized, in that CSA significantly related to higher depressive symptoms 
only for women scoring low in resilience, but not for women scoring high in 
resilience. This finding in a sample of HIV infected and uninfected women is 
important given the high prevalence of abuse histories among HIV infected and 
uninfected women and the association between trauma and negative health 
outcomes in this population (M. Cohen et al., 2000; M. H. Cohen et al., 2004; 
Machtinger, Haberer, et al., 2012). The results are consistent with results by 
Wingo and colleagues (2010) who found that resilience moderated the 
relationships between trauma and depression scores in a community sample 
such that the high resilience group reported lower depression scores than the 
medium and low resilience groups.  
 In developing the CD-RISC, Connor and Davidson (2003) viewed 
resilience as consisting of both personal qualities that help an individual to 
succeed in the face of adversity and as a measure of successful coping/adaption 
in response to stress. The CD-RISC captures both personality traits and 
successful coping via items such as “I am able to adapt when changes occur” 
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and “I think of myself as a strong person when dealing with life's challenges and 
difficulties”. Women with CSA who score highly on this scale are endorsing items 
that indicate that they have a positive view of themselves as strong and capable 
of dealing with adversity.  These types of positive self-attributions may contra-
indicate depressive symptoms, in that women high in resilience may not be as 
susceptible to depressive symptoms or may respond more adaptively to the 
onset of depressive symptoms (e.g. by seeking support) and therefore prevent 
further exacerbation of depressive symptoms. It is also possible that resilience 
and low depressive symptoms are linked by a commonality in self-presentation or 
response biases:  women who are likely to report they are strong and confident 
may also be less likely to report any vulnerabilities such as depressive 
symptoms.   
Our findings among HIV+ and HIV- women that resilience relates to lower 
depressive symptoms and higher health related quality of life, and mitigates the 
relationship between childhood sexual abuse and depressive symptoms, make a 
new contribution to the literature and highlight the importance of promoting 
resilience in prevention and intervention strategies.  Increasing resilience among 
HIV infected and uninfected women could lower depressive symptoms, increase 
health related quality of life, and especially mitigate the impact of CSA on 
depressive symptoms, thus potentially promoting better physical health 
outcomes, since depressive symptoms are associated with medication 
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nonadherence and HIV disease progression(Cook et al., 2004; Leserman et al., 
2007).  
There are findings in the literature to support the feasibility and possible 
effectiveness of a resilience intervention for HIV infected and uninfected women 
with histories of CSA.  Among women and men infected with HIV and reporting 
histories of CSA, Sikkema and colleagues (2007; 2008) found that interventions 
for coping with HIV and CSA (thereby promoting resilience) reduced traumatic 
stress symptoms and the frequency of unprotected sexual intercourse. Another 
study indicated that during a period of increased academic stress for college 
students, a resilience intervention significantly increased resilience scores and 
effective coping strategies and decreased depressive symptoms, perceived 
stress and negative affect (M. Steinhardt & Dolbier, 2008).  
Building resilience among HIV infected and uninfected women with 
histories of CSA might be targeted in individual and/or group therapy. Sessions 
could address coping/processing CSA and encourage resilient strategies such as 
viewing adversity as a challenge/opportunity. The CD-RISC resilience measure 
can be used as assessment tool at baseline, at several points during therapy and 
after treatment completion. Additional research needs to be conducted to 
adequately develop and test the efficacy of such an intervention.  
Findings from this study should be interpreted within the context of the 
limitations of a cross-sectional study design that prevents drawing causal 
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conclusions, potential recall bias regarding CSA, and self-report measures of 
resilience, depressive symptoms and HRQOL that are subject to social 
desirability factors.  In addition, some have argued that resilience is better 
understood as a trajectory of healthy functioning following a traumatic event 
(Bonanno, 2012), and therefore longitudinal designs examining the resilience 
trajectory of HIV infected and uninfected women are needed.  Nonetheless, our 
finding that a cross-sectional measure of resilience related to lower depressive 
symptoms and higher quality of life, and buffered the impact of CSA on 
depressive symptoms provides implications for future studies of resilience among 
women with and at risk for HIV and the development of prevention and 
intervention efforts.  
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Table 2.1  Sociodemographic statistics, clinical characteristics, and subsample   
comparisons 
 
Entire 
sample 
HIV + 
women HIV - women 
HIV+ and HIV- 
Comparison 
  (N = 202) (n = 138) (n = 64) χ
2 
 n (%) n (%) n (%)  
Race 
   White / non- 
   Hispanic 8 (4) 6 (4.3) 2 (3.1) 
χ2 (7, N =202)    
= 3.58, p =.83 
   White / Hispanic 10 (5) 6 (4.3) 4 (6.3)  
   African-Amer / non-   
   Hispanic 175 (87) 120 (87) 55 (85.9) 
 
African-Amer /  
   Hispanic 3 (1.5) 1 (0.7) 2 (3.1) 
 
   Other / Hispanic 3 (1.5) 2 (1.4) 1 (1.6)  
   Other 3 (1.5) 3 (2.1) 0 (0.0)  
Education    
χ2 (5, N =202)    
= 8.83, p =.12 
   Grade 11 or less 77 (38.1) 60 (43.4) 17 (26.6)  
   Completed high  
   School 58 (28.7) 38 (27.5) 20 (31.3) 
 
   Some or complete  
   College 65 (32.1) 38 (27.5) 27 (42.2) 
 
   Attended/completed   
   graduate school 2 (1) 2 (1.4) 0 (0.0) 
 
Income    
χ2 (2, N = 200) 
=11.30, p = .01 
   $6,000 or less 55 (27.2) 30 (21.7) 25 (39.1)  
   $6,001-$12,000 79 (39.1) 64 (46.4) 15 (23.4)  
   $12,001 and above 66 (32.7) 42 (30.4) 24 (37.5)  
Employed  48 (23.8) 25 (18.1) 23 (35.9) 
χ2 (1, N = 201) 
=8.05, p = .01 
Marital Status    
χ2 (5, N = 201)    
= 5.85, p= .32 
  Legally/common-   
  law marriage 31 (15.3) 20 (14.5) 11 (17.2) 
 
  Not married but     
   living w partner 13 (6.4) 9 (6.5) 4 (6.3) 
 
   Widowed 13 (6.4) 12 (8.7) 1 (1.6)  
   Divorced/Annulled 30 (14.9) 21 (15.2) 9 (14.1)  
   Separated 19 (19.4) 15 (10.9) 4 (6.3)  
   Never married 95 (47) 60 (43.5) 35 (54.7)  
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 Mean (SD) t (p)/ χ
2 
Age 45.23(8.43) 45.74(8.38) 44.14(8.50) -1.25 (p = .21) 
Childhood Sexual Abuse 54(26.7) 41(29.7) 13(20.3) 
χ2 (1, N =198)    
= 2.05, p =.15 
Resilience (CD-RISC) 29.14(7.55) 28.82(7.8) 29.84(7.01) .93 (p = .35) 
Depressive Symptoms 
(CES-D) 12.65(10.58) 13.28(10.83) 11.28(9.96) 
 
-1.29 (p = .20) 
Quality of Life (HRQOL) 67.24(20.76) 64.05(20.68) 76.71(18.14) 3.77(p=.001) 
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Table 2.2 Partial correlations between sociodemographic variables and outcomes 
controlling for HIV status 
  
Variable 1   2   3   4   5 
1. Age       
2. Education Level  .02     
3. Employment Status  -.18* .31***    
4. Annual Household Income .05 .31*** .39***   
5. WIHS Enrollment Wave  -.25*** .00 -.01 -.11  
6. Childhood Sexual Abuse (CSA) .24** .16* .02 .06 -.36*** 
7. Resilience (CD-RISC) .002 .21** .24** .16* -.09 
8. Quality of Life (HRQOL) -.25** .10 .24** .12 .06 
9. Depressive Symptoms (CES-D) .03 -.27*** -.18* -.26*** .13 
 Note. *p < .05,** p < .01,  ***p < .001.  
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Figure 2.1 Resilience moderates the relationship between childhood sexual abuse 
and depressive symptoms  
 
	  
Note: CSA= Childhood sexual abuse.  
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CHAPTER THREE 
Study #2: Abuse and Resilience in Women with HIV 
in Relation to HAART Medication Adherence and HIV Viral Load 
Introduction 
 In a sample of HIV infected women, study 2 investigated whether 
resilience related to HIV health outcomes (disease progression i.e. detectable 
viral load and CD4+ cell count) and highly active antiretroviral therapy (HAART) 
adherence and also moderated the relationships of abuse history with HIV 
medication adherence and HIV biomarkers (viral load and CD4+ cell count). A 
secondary aim was to also investigate if the relationships between resilience and 
HAART adherence and resilience and HIV biomarkers were mediated by 
depressive symptoms. With access to HAART in the US, HIV is a manageable 
chronic illness, however a high rate of adherence (i.e. 95% or greater) is 
necessary to suppress HIV viral load and boost immune response via CD4 cell 
counts (Garcia de Olalla et al., 2002; Palella et al., 1998; Paterson et al., 2000; 
Wood et al., 2004). Unfortunately most HIV+ individuals are adhering at a rate 
lower than 95% in the US (Golin et al., 2002; Mannheimer et al., 2002), which 
can have deleterious outcomes, including the development of drug resistant 
strains of HIV (Lucas, 2005; Richman et al., 2004; Wainberg & Friedland, 1998). 
Prevalent histories of abuse and depression among women with HIV have been 
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linked to HIV medication nonadherence, antiretroviral failure and increased 
mortality (Arriola, Louden, Doldren, & Fortenberry, 2005; Cohen et al., 2004; 
Cohen et al., 2002; Keuroghlian et al., 2011; Leserman et al., 2007; Machtinger, 
Haberer, et al., 2012; Meade, Hansen, Kochman, & Sikkema, 2009).  
 As indicated by study 1, resilience may be protective against negative 
health outcomes and related to lower depressive symptoms and higher health-
related quality of life in both women with and at risk for HIV. Study 2 expands on 
the results of study 1 by exploring resilience and abuse in relation to HIV disease 
markers and HAART adherence in women with HIV, as well as whether these 
relationships are mediated by depressive symptoms.  No previous literature has 
reported a link between resilience and HAART adherence or HIV disease 
markers, but a limited number of studies have reported that positive coping 
strategies (e.g. meaning making and conscientiousness) are related to better 
HAART adherence and disease markers (Ickovics et al., 2006; O'Cleirigh et al., 
2007). In contrast, depression is associated with nonadherence to HAART and 
mortality (Ickovics et al., 2001; Leserman et al., 2007) among women with HIV.  
These studies suggest that resilience has the potential to relate to better 
medication adherence and HIV disease markers and possibly buffer the negative 
influence of abuse histories on medication adherence and HIV disease markers; 
and that these relationships may be mediated by depressive symptoms.   
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The present study hypothesized that (1) sexual abuse, physical abuse, 
and domestic violence histories would relate to lower HAART medication 
adherence, detectable viral loads, CD4+ cell count below 200 and higher 
depressive symptoms (2) women scoring high on resilience compared to women 
scoring low on resilience would have higher medication adherence, undetectable 
viral loads, and CD4+ cell count above 200 (3) depressive symptoms would 
relate to lower resilience, lower HAART medication adherence, detectable viral 
loads, and CD4+ cell count below 200 (4) depressive symptoms would mediate 
the relationships between resilience and HAART medication adherence, 
undetectable viral loads, and CD4+ cell count above 200 and (5) resilience would 
moderate the relationships between sexual abuse, physical abuse and domestic 
violence histories and medication adherence, detectable viral load, and lower 
CD4+ cell count, such that abuse histories would predict poor health outcomes 
(e.g. lower medication adherence, detectable viral loads, and CD4+ cell count 
below 200) only for women scoring low on resilience, but not for women scoring 
high on resilience. This study also explored whether sexual abuse, physical 
abuse, domestic violence, and abuse composite scores directly related to 
resilience scores. 
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Methods 
Participants and Procedure 
During 2011 and 2012 138 HIV+ women at the Chicago CORE center site 
of the Women's Interagency HIV Study (WIHS) from three enrollment waves 
(wave 1: 1994 – 1995, n= 38; wave 2: 2001-2002, n= 57; and wave 3: 2011-
2012, n= 43) were approached and participated in this study. Demographics of 
the sample are presented in the Results section below. Chicago WIHS is one of 
six WIHS sites in the United States. WIHS is a prospective cohort study designed 
to better understand HIV disease in women.  The study methodology has 
previously been reported (Bacon et al., 2005; Barkan et al., 1998). In brief, 
women are seen every six months for study visits which include a questionnaire 
on sociodemographics (e.g. substance use and employment), short physical 
exam and collection of blood and gynecological specimens. Women were given 
transportation support, childcare, and a financial honorarium of $25 for their time 
and effort. The study protocol was approved by Institutional Review Boards of 
Boston University and John H. Stroger Jr Hospital of Cook County as well as the 
WIHS Executive Committee.  
Measures 
Sexual Abuse, Physical Abuse and Domestic Violence Histories. To 
assess for recent sexual abuse women were asked “Since your (MONTH) study 
visit, has anyone pressured or forced you to have sexual contact? By sexual 
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contact I mean them touching your sexual parts, you touching their sexual parts 
or sexual intercourse?” For recent physical abuse women were asked “Since 
your (MONTH) study visit, have you experienced serious physical violence 
(physical harm by another person)? By that I mean were you ever hurt by a 
person using an object or were you ever slapped, hit, punched, kicked?” To 
gather information on women’s experience of recent domestic violence, a total of 
seven questions were asked such as “Since your (MONTH) study visit, has a 
current or previous partner threatened to hurt or kill you?” and “Since your 
(MONTH) study visit, has a current or previous partner prevented you from 
seeing friends?” Women were asked these questions at their baseline visit to 
capture any prior adult or childhood experience of sexual abuse, physical abuse 
and domestic violence and then again each year over the course of their 
enrollment in WIHS (range 1-18 years). Baseline questions began with “at any 
time in your life” instead of “since your (MONTH) study visit.” To gather 
information on childhood sexual abuse at baseline women were also asked the 
follow-up question “How old were you when this first happened?” and below age 
18 years was coded as childhood sexual abuse. Summary variables were 
created to capture any history of sexual abuse, physical abuse, or domestic 
violence (0=no reported history, 1=history of abuse report) as well as an abuse 
composite score summing all three types of abuses (0=no reported history of 
abuse, 1= one abuse, 2=two abuses, 3=three abuses).  
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Substance abuse. At the study visit data was gathered for participants’ 
self-report use of alcohol and illicit drugs (intravenous drugs, crack, cocaine, and 
heroin) based on the National Institute on Alcohol Abuse and Alcohol (NIAAA) 
criteria for heavy alcohol drinking in women (four or more standard drinks in a 
day) and the National Institute on Drug Abuse (NIDA) recommendations for the 
measurement of illicit drug use. Two categories were created for substance 
abuse variables: (1) current or former and (2) no current or no former use. 
Connor-Davidson Resilience Scale -10 item (Campbell-Sills & Stein, 
2007). The 10-item CD-RISC is an abbreviated and more reliable version of the 
original 25-item CD-RISC (Connor & Davidson, 2003). The scale captures 
personality traits and adaptive coping strategies that enhance an individual’s 
ability to strive despite adversity via items such as “I believe I can achieve my 
goals, even if there are obstacles” and “I am not easily discouraged by failure.” 
Respondents rate the 10 items on a scale from 0 (not true at all) to 4 (true nearly 
all the time) and total scores range from 0 to 40 with higher scores reflecting 
greater resilience. The CD-RISC-10 has demonstrated good internal consistency 
(Cronbach’s α coefficient = .85) and construct validity, with CD-RISC scores 
moderating the relationship between childhood maltreatment, trauma exposure, 
and psychiatric symptoms in the general population (Campbell-Sills & Stein, 
2007). In the current sample the Cronbach’s alpha reliability coefficient was .91.  
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HAART adherence. Women were asked how often they took their 
HAART medication as prescribed during the 6 months before the current study 
visit. Each woman was asked to bring in her medication bottles or a list from the 
pharmacy or physician or to identify the medications from the picture cards 
provided by WIHS staff.  She was then asked to specifically recall her adherence 
to each drug of her current HAART regimen by pinpointing on a response card 
(showing percentages from 0-100%) her best guess at the percentage of the 
specific pills she took. These self-report adherence measures have been found 
to have reliable concurrent and predictive validity with measures of disease 
progression including viral load and CD4 count (Lazo et al., 2007; Nieuwkerk & 
Oort, 2005; T. E. Wilson et al., 2002).  Using similar measures Paterson, 
Swindells, and Mohr (2000) found that HIV disease progression is significantly 
inhibited with reported HAART adherence greater than or equal to 95%. A 
categorical variable was created from our measure of adherence with 1= 
adherence rate >/= 95% and 0= less than 95% adherence or not taking HAART 
although HAART was medically indicated at the current or previous visit based 
on a CD4+ cell count below 500.    
HIV disease progression. Semi-annual immunologic disease progression 
was assessed by CD4+ cell counts, and virologic disease progression was 
assessed by HIV RNA load, given in copies per milliliter of blood. AIDS Clinical 
Trials Group (ACTG) certified laboratories measured CD4+ cells/mm3 by 
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immunofluorescence using flow cytometry; and in laboratories participating in the 
National Institutes of Health Viral Quality Assurance Program, HIV-1 RNA levels 
were assessed using an isothermal nucleic acid sequence–based amplification 
(NASBA/Nuclisens) method, which has a detection limit of 20 copies/mL. 
Consistent with the CD4+ cell count below 200 meeting criteria for the definition 
for AIDS (Centers for Disease Control and Prevention, 1992), we used a 
categorical CD4+ cell count cut-off of 200 in our analyses. Viral load was 
dichotomized as undetectable (< 20 copies/ml) and detectable (≥ 20 copies/ml).  
Center for Epidemiological Studies Depression Scale (CES-D 
Scale)(Radloff, 1977). The CES-D is a widely used self-report measure of 
current affective depressive symptoms, which was previously described in the 
Methods section of study 1.  
 
Statistical Analyses 
SPSS version 19.0 was used to analyze the data with Pearson 
correlations, independent samples t-test, and hierarchical multiple linear 
regressions. Participants’ CD-RISC resilience scores were analyzed in relation to 
sexual abuse, physical abuse, domestic violence, composite abuse variable, 
depressive symptoms, HAART adherence, detectable viral load, and CD4+ cell 
count with a cutoff of 200. A few participants were missing data on some 
measures. One participant was missing data on sexual abuse history and 9 
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participants did not have HAART adherence data because they were not 
medically indicated to be on HAART. Missing items were treated as missing in all 
data analyses.  
Results 
Eight-seven percent of the sample of 138 HIV+ women self-identified as 
African American, 28% completed high school and 24% attended some college. 
Of the 138 women 55% percent reported adult and/or childhood sexual abuse, 
75% reported physical abuse, 62% reported a history of domestic violence, and 
42% reported a history of all three type of abuse. A history of substance use was 
also prevalent in our sample: heavy drinking (current=26.8%; former=26.1%), 
crack/cocaine/ heroin (current=16.7%; former=51.4%), and intravenous drug use 
(current=1.4%; former=29%).  Mean CD-RISC resilience score was 28.82 (7.8) 
and 27.5% of women were nonadherent to HAART (<95%). Table 1 displays 
descriptive statistics for the study’s predictor and outcome variables as well as 
the sample socio-demographics.  
----------------------------------------------------------- 
Insert Table 1 about here 
---------------------------------------------------------- 
Preliminary Analyses 
Pearson correlations as displayed in Table 2 showed that age, income, 
education, enrollment wave, and substance use each significantly related to 
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some predictors and/or outcomes and consequently were included as covariates 
in regression analyses.  Bivariate correlations also indicated that >95% HAART 
adherence significantly related to undetectable viral load (r = -.46, p = .001) and 
CD4+ count above 200 (r = .18, p = .05); and undetectable viral load was 
significantly associated with CD4+ count above 200 (r = -.18, p = .05). A history 
of sexual abuse was significantly related to physical abuse (r = .40, p = .001) and 
domestic violence (r = .42, p = .001) and physical abuse and domestic violence 
were significantly associated with each other (r = .42, p = .001).   
------------------------------------------------------------- 
Insert Table 2 about here 
------------------------------------------------------------- 
Hypothesis 1: Relationships between abuse histories, HAART adherence, 
HIV disease markers, and Depressive Symptoms  
 To test the hypothesis that abuse histories would relate to lower 
medication adherence, detectable viral loads, CD4+ cell count below 200, and 
higher depressive symptoms hierarchical multiple linear regressions were run 
while controlling for age, education, employment, income, wave, and substance 
use. Covariates were entered in block 1; sexual abuse, physical abuse, domestic 
violence or abuse composite score were entered separately, each in an 
independent regression, as a main effect in block 2, and outcomes were HAART 
adherence, detectable viral load, CD4 cutoff of 200, and depressive symptoms 
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with each outcome also tested in independent regressions.  Results indicated 
that a history of domestic violence approached significance in associating with 
lower HAART adherence (β = -.15, t = -1.82, p = .07), but there were no 
significant relationships between sexual or physical abuse and abuse composite 
score with HAART adherence, HIV disease markers, or depressive symptoms.  
Exploratory Hypothesis: Relationships between abuse histories and 
resilience 
 Hierarchical multiple linear regressions were used to explore the 
relationships between sexual abuse, physical abuse, domestic violence, abuse 
composite score and resilience while controlling for age, education, employment, 
income, wave, and substance use. Covariates were entered in block 1, sexual 
abuse, physical abuse, domestic violence or abuse composite score were 
entered separately, each in an independent regression, as a main effect in block 
2, and resilience was the outcome. None of the abuse variables significantly 
related to resilience.  
 
Hypothesis 2: Relationships between resilience, HAART adherence, and 
HIV disease markers  
 Hierarchical multiple linear regressions were run to test the hypothesis 
that women scoring high on resilience compared to women scoring low on 
resilience would have higher medication adherence, undetectable viral loads, 
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and CD4+ cell count above 200 while controlling for age, education, employment, 
income, wave, and substance use. Covariates were entered in block 1, resilience 
was entered as a main effect in block 2, and outcomes were HAART adherence, 
CD4+ cutoff at 200, and detectable viral load.  Findings showed that resilience 
was significantly negatively related to detectable viral load (β = -.22, t = -2.45, p = 
.02) and approached significance in positively relating to HAART adherence (β = 
.14, t = 1.68, p = .10) indicating that higher resilience scores tended to relate to 
better medication adherence and significantly related to having undetectable viral 
load.  
 Based on these findings Stata 11.0 was used to run a mediation analysis 
to test whether HAART adherence mediated any portion of the relationship 
between resilience and undetectable viral load and to determine the size and 
significance of the direct and indirect effects with bootstrap analyses. In the 
command, resilience was the predictor, detectable viral load was the outcome, 
HAART adherence was the mediator and covariates were income, education, 
employment, age, wave, and substance use. Results indicated that the indirect 
effect from resilience through HAART adherence to undetectable viral load was 
not significant, indicating that the relationship between resilience and 
undetectable viral load was not significantly mediated by adherence to HAART.  
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Hypothesis 3: Relationships between Depressive Symptoms, Resilience, 
HAART adherence, and HIV disease markers  
 To test the hypothesis that depressive symptoms would relate to lower 
resilience, lower HAART medication adherence, detectable viral loads, and CD4+ 
cell count below 200, hierarchical multiple regressions were conducted. 
Covariates of age, education, employment, income, wave, and substance use 
were entered in block 1, depressive symptoms were	  entered as a main effect in 
block 2, and outcomes were resilience, HAART medication adherence, CD4+ 
cutoff at 200, and detectable viral load. Results indicated that higher depressive 
symptoms were significantly related to lower resilience (β = -.49 t = -6.21, p = 
.001) and lower HAART adherence (β = -.19 t = -2.24, p = .03), but were not 
related to detectable viral load or CD4+ cutoff at 200.  
Hypothesis 4: Depressive symptoms mediating relationships of resilience 
with HAART adherence and HIV disease markers  
 According to Holmbeck (1998) three conditions need to be satisfied to 
suggest mediation: (1) predictor (resilience) significantly relates to the outcome 
(2) predictor significantly relates to the mediator (depressive symptoms) and (3) 
mediator significantly relates to the outcome. Findings above noted that 
resilience significantly related to undetectable viral load and showed a trend of 
relating to higher HAART medication adherence, but did not relate to CD4+ cell 
count. In study 1 resilience significantly related to lower depressive symptoms 
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and in the present study that was comprised of the subsample of HIV+ women 
from study 1, resilience and depression were significantly related. In the present 
study, depressive symptoms significantly related to lower HAART medication 
adherence, but did not significantly relate to detectable viral load or CD4 cell 
count. Thus, the results on which to base mediational analyses were somewhat 
satisfied to test the hypothesis that depressive symptoms would mediate the 
relationship between resilience and HAART medication adherence. To 
investigate whether depressive symptoms mediated the relationships between 
resilience and HAART medication adherence Stata 11.0 was used to run a 
mediation analysis that provided the size and significance of the direct and 
indirect effects with bootstrap analyses. In the command, resilience was the 
predictor, HAART adherence was the outcome, depressive symptoms were the 
mediator and the covariates were income, education, employment, age, wave, 
and substance use. Results indicated that the indirect effect from resilience 
through depressive symptoms to HAART adherence was not significant, 
indicating that the relationship between resilience and HAART adherence was 
not mediated by depressive symptoms. 
Hypothesis 5: Resilience moderating relationships of abuse histories with 
HAART adherence and HIV disease markers  
Analyses were conducted to test if resilience would moderate the 
relationships between sexual abuse, physical abuse and domestic violence 
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histories and medication adherence, detectable viral load, and lower CD4+ cell 
count, such that abuse histories would predict poor health outcomes (e.g. lower 
medication adherence, detectable viral loads, and CD4+ cell count below 200) 
only for women scoring low on resilience, but not for women scoring high on 
resilience. Two-way dummy interaction terms were created by multiplying 
standardized scores of abuse histories (sexual abuse, physical abuse, domestic 
violence or abuse composite score) and standardized resilience scores. 
Hierarchical multiple linear regressions included the covariates:  age, income, 
education, employment, wave, and substance use entered in block 1; abuse 
histories (each in independent regressions) and resilience entered as main 
effects in block 2, and the dummy variables representing the interaction of 
resilience with abuse histories entered in block 3.  The outcome variables of 
HAART adherence, detectable viral load, and CD4 cutoff of 200 were tested in 
independent regressions. Results indicated that the interactions between 
resilience and sexual abuse (β = .22, t = 2.65, p = .009) and resilience and abuse 
composite score (β = .19, t = 2.29, p = .03) significantly related to HAART 
adherence, but did not significantly relate to detectable viral load and CD4 cutoff 
of 200. The interactions between resilience and physical abuse or domestic 
violence did not significantly relate to CD4 cutoff of 200, detectable viral load, 
and HAART adherence.  
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 Follow-up regression analyses were done to explore the meanings of the 
significant interactions (i.e. resilience and sexual abuse and resilience and abuse 
composite score) to investigate how resilience moderated the relationships 
between sexual abuse history and HAART adherence, and between abuse 
composite score and HAART adherence. Based on Holmbeck’s methods (1998, 
2002), high and low resilience scores were separated into two groups (high: 1 SD 
above the mean, N= 27; low: 1 SD below the mean, N = 29) and post hoc 
regressions were run separately for each group with covariates of age, income, 
education, employment, wave, and substance use entered in block 1, sexual 
abuse or abuse composite score entered in independent regressions as the main 
effects in block 2, and HAART adherence as the outcome. For the low resilience 
score group, sexual abuse significantly related to lower HAART adherence (β = -
.39, t = -2.64, p = .02), but for the high resilience score group sexual abuse did 
not relate to HAART adherence. Similarly, higher abuse composite score 
significantly related to lower HAART adherence only for women reporting low 
resilience (β = -.35, t = -2.43, p = .03), but not for women reporting high 
resilience.  
------------------------------------------------------------- 
Insert Figure 1 about here 
------------------------------------------------------------ 
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Discussion 
 Several of our major hypotheses were confirmed showing that resilience is 
an important factor that may place women with HIV “at promise” for better HIV 
health outcomes. A higher resilience score was significantly related to having 
undetectable viral load and approached significance in relating to HAART 
adherence >/= 95%, indicating that HIV infected women who scored higher on 
resilience are more likely to have undetectable viral loads and tended to be more 
likely to report taking their medications at a rate that has been shown to 
effectively suppress the virus.  
 Resilience also significantly moderated relationships between sexual and 
overall abuse histories with HAART adherence. For women with HIV, having a 
history of sexual abuse or multiple abuses in combination with low resilience 
predicted low HAART medication adherence (</=95%), but in combination with 
high resilience, sexual abuse did not predict HAART adherence. This speaks to 
the potential power of resilience in promoting HAART adherence for women with 
HIV who have histories of sexual abuse.  
 A history of domestic violence approached significance in relating to lower 
medication adherence.  This relationship is consistent with previous literature 
noting that abuse/trauma is associated with HIV medication nonadherence 
(Mardge H. Cohen et al., 2004). Perhaps due to our somewhat small sample size 
the relationship between domestic violence and HAART adherence only 
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approached significance and we did not find significant direct associations 
between history of sexual or physical abuse with HAART adherence, detectable 
viral load, and CD4 cutoff of 200. Similarly, we did not detect any direct 
associations between sexual or physical abuse histories and resilience, as 
consistent with previous literature in which associations between resilience and 
abuse histories have been rare(Campbell-Sills & Stein, 2007; Scali et al., 2012; 
Wingo et al., 2010). Experiencing abuse alone does not guarantee that one will 
develop adaptive coping strategies and personal qualities; in fact many survivors 
have negative outcomes. However, having or developing such qualities and 
strategies is what defines resilience as measured by the CD-RISC. Therefore it is 
not surprising that abuse histories did not directly relate to resilience scores.  
 Surprisingly depressive symptoms were also not significantly associated 
with any abuse histories, which is in contrast to previous literature (Boudewyn & 
Liem, 1995; Hegarty, Gunn, Chondros, & Small, 2004). In accordance with 
existing literature, higher depressive symptoms significantly related to lower 
HAART medication adherence (Ickovics et al., 2001; Leserman et al., 2007). 
However, depressive symptoms did not mediate the relationship between 
resilience and HAART adherence suggesting that the path by which resilience 
may relate to better medication adherence is not through its influence on 
lowering depressive symptoms.  
	  	  
	  
	  
67 
 Our overall findings support the argument that in women with HIV, abuse 
histories may relate to poor HAART adherence and HIV disease markers only in 
the presence of low resilience scores. Findings were limited by a cross-sectional 
study design, but suggest that intervention efforts aimed at promoting better 
health outcomes for women with HIV should incorporate aspects that target 
resilience (e.g., encouraging women to view stressors and challenges as things 
they can overcome). Interventions that have targeted resilience have provided 
some evidence for feasibility and effectiveness (Steinhardt, Mamerow, Brown, & 
Jolly, 2009;  Steinhardt & Dolbier, 2008). For instance, a resilience intervention 
by Steinhardt and colleagues (2008) with college students consisted of sessions 
highlighting responses to stress (e.g., stepping up versus giving up), problem-
focused coping (e.g., active planning), recognizing one’s power to make 
decisions and influence situations, making empowering and adaptive 
interpretations of situations, and having meaningful relationships with others.  
Authors found that this intervention increased resilience scores (on the CD-RISC 
and Dispositional Resilience Scale), increased effective coping strategies (e.g. 
problem solving), and decreased perceived stress, negative affect, and 
depressive symptoms. Future studies are needed among women with HIV to 
investigate changes in resilience over time in relation to their health outcomes 
and develop interventions to improve women’s resilience.	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Table 3.1  Sample characteristics and socio-demographic statistics of 138 
participants.  
Characteristics  Mean (SD) 
 Age 45.74 (8.38) 
Resilience (CD-RISC) 28.82 (7.8) 
 
 n (%) 
Domestic Violence  86 (62.3) 
Physical Abuse 104 (75.4) 
Sexual Abuse 76 (55.1) 
Abuse composite (all 3 abuses) 58 (42) 
ART adherence (<95%)  38 (27.5) 
Detectable viral load (≥ 20 copies/ml) 50 (36.2) 
Below CD4 cutoff of 200 21 (15.2) 
Depressive Symptoms (CES-D) 13.28 (10.83) 
Race 
   White / non-Hispanic 6 (4.3) 
   White / Hispanic 6 (4.3) 
   African-American / non- Hispanic 120 (87) 
   African-American / Hispanic 1 (.7) 
   Other / Hispanic 2 (1.4) 
   Asian / Pacific Islander 1 (.7) 
   Native American / Alaskan 1 (.7) 
   Other  1 (.7) 
Education  
   Grade 11 or less 60 (43.4) 
   Completed high school 38 (27.5) 
   Some college  33 (23.9) 
   Completed college 5 (3.6) 
   Attended/completed graduate 
school 2 (1.4) 
Income  
   $6,000 or less 30 (21.7) 
   $6,001-$12,000 64 (46.4) 
   $12,001 or more 42 (30.4) 
Employed  25 (18.1) 
Marital Status  
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Legally/common- law marriage 20 (14.5) 
  Not married but living w partner 9 (6.5) 
   Widowed 12 (8.7) 
   Divorced/Annulled 21 (15.2) 
   Separated 15 (10.9) 
   Never married 60 (43.5) 
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Table 3.2  Pearson’s correlations between sociodemographic variables, abuse, HIV 
disease markers, and depressive symptoms.  
        
Variable 1   2   3   4   5 6 7 8 
1. Age          
2. Education Level  .03        
3. Employment Status  -.21* .25**       
4. Annual Household    
    Income  
.01 .26** .26**      
5. WIHS Enrollment  
    Wave  
-.40*** .01 .05 -.04     
6. Alcohol (heavy  
   drinking) 
.05 -.03 .07 .03 -.16    
7. Crack/Cocaine/Heroin .22** -.16 -.23** -.17 .03 .15   
8. Intravenous Drug Use .44*** -.01 -.23** -.18* -.26** .19* .40***  
9. Resilience (CD-RISC)  .05 .16 .15 .13 -.15 .07 -.27** -02 
10. Domestic Violence  .08 -.06 .02 -.08 -.24** .10 .18* .08 
11. Physical Abuse  .16 .01 -.08 -.03 -.13 .06 .27** .10 
12. Sexual Abuse  .23** .08 .08 .005 -.12 .11 .23** .33*** 
13. Abuse Composite  .19* .02 .01 -.04 -.21* .12 .29** .22* 
14. HAART adherence  .32*** .05 .06 -.003  .07 -.22* -.03 .13 
15. Detectable viral load  -.21* -.13 -.08 -.007  .02 .15 -.01 -.03 
16. CD4 cutoff of 200 -.003 .08 -.01 .17 .02 -.03 -.15 .03 
17. Depressive  
     Symptoms (CES-D) 
-.02 -.23** -.07 -.22* .17* .03 .25** .07 
  Note. *p < .05,** p < .01,  ***p < .001.  
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Figure 3.1  Regression lines for associations between abuse composite and HAART 
adherence as moderated by resilience. 
 
 
Note: HAART= Highly active antiretroviral therapy. Low/high abuse refers to low/high 
abuse composite score summing all three types of abuses. 
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CHAPTER FOUR 
Study #3: Resilience, Stress Hormones, and  
Coronary Heart Disease Risk Among Women with HIV 
Introduction  
 Death in HIV infected persons is now increasingly due to non HIV-related 
causes such as coronary heart disease (CHD; (Sackoff, Hanna, Pfeiffer, & 
Torian, 2006). There is a high prevalence of abuse histories among women with 
HIV (Machtinger, Wilson, et al., 2012) and abuse has been associated with 
increased risk of heart disease, which is not surprising given that some 
consequences of abuse (e.g. obesity and substance use) are also linked to heart 
disease (Dong et al., 2004; Kendall-Tackett, 2002). The pathway by which abuse 
results in negative physical consequences such as CHD is theorized to be 
partially connected to activity in the hypothalamic-pituitary-adrenal (HPA) axis, 
including the regulation of the stress hormones cortisol and norepinephrine 
(Hulme, 2011; Jokinen & Nordstrom, 2009; Midei et al., 2013).  
Cortisol and norepinephrine are neurotransmitters that play a key role in 
the body’s biological and behavioral response to stress and they may become 
dysregulated among individuals exposed to trauma/abuse (Mangold, Wand, 
Javors, & Mintz, 2010).  Dysregulation has been defined as abnormal total levels, 
or abnormal response levels) and dysregulated levels of cortisol and 
norepinephrine have shown significant associations with heart disease risk (Cole, 
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Korin, Fahey, & Zack, 1998; Cole et al., 2001; Cole et al., 2003), although 
previous literature is inconsistent and unclear about whether it is higher or lower 
levels of NE and cortisol that is related to CHD risk (Ji, Guo, Yan, Li, & Lu, 2010; 
Jokinen & Nordstrom, 2009; Makheja, Bloom, Muesing, Simon, & Bailey, 1989; 
Straub et al., 2002; Thomas & Marks, 1978).  
Despite histories of abuse, women with HIV may be resilient (function 
adaptively in the face of or following adversity) and develop positive self-esteem 
(Singleton, 2004; Smith et al., 2005).  Their resilience and positive self-esteem 
may be linked to lower risk for heart disease. Only a few investigators have 
studied resilience (or hardiness) in relation to heart disease risk (and risk factors) 
and no published studies have investigated bidirectional relationships between 
self-esteem and heart disease risk. However, the scant literature does suggest 
that resilience and positive self-esteem may relate to lower CHD risk (Bartone et 
al., 2009; M. Cohen et al., 2007; Kasl & Cobb, 1995).  
Resilience and positive self-esteem may also be associated with levels of 
cortisol and NE, which have been linked to heart disease (Cicchetti & Rogosch, 
2007; Pruessner et al., 2004; Scarpa & Luscher, 2002; Seeman et al., 1995). 
However, the current literature investigating associations between psychological 
factors such as resilience and PSE with stress hormones is minimal.  A few 
studies found that higher self-esteem was associated with lower levels of cortisol 
(Pruessner et al., 2004; Scarpa & Luscher, 2002; Seeman et al., 1995); and 
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higher resilience was associated with higher cortisol levels in physically abused 
children and lower morning cortisol levels in nonmaltreated children (Cicchetti & 
Rogosch, 2007). 
Study 1 reported that resilience was significantly and inversely associated 
with depression. Further, depression is a noted consequence of abuse histories 
(Boudewyn & Liem, 1995; Hegarty et al., 2004) and individuals with depression 
have also shown dysregulated levels of cortisol and norepinephrine (Butler, 
Hokanson, & Flynn, 1994; Franck & De Raedt, 2007). Studies have also reported 
a link between depression and increased heart disease risk (Khawaja et al., 
2009). Thus, depressive symptoms may be a potential mediator of relationships 
between resilience, stress hormones and CHD risk.  
Present Study  
The present study investigated the relationships among resilience, positive 
self-esteem, abuse histories, levels of stress hormones (i.e. norepinephrine and 
cortisol) and coronary heart disease (CHD) among women with HIV. We 
hypothesized that (1) abuse histories would be associated with higher CHD risk; 
(2) resilience and positive self-esteem would be negatively associated with (a) 
abuse histories and (b) CHD risk, (3) higher depressive symptoms would be 
associated with abuse histories, lower resilience, lower positive self-esteem, and 
higher CHD risk, and (4) depressive symptoms would mediate relationships 
between resilience, positive self-esteem, and abuse histories with CHD risk. 
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Further, additional exploratory questions involved investigating whether total 
levels of NE and cortisol as well as NE/cortisol ratio were significantly associated 
with CHD risk, abuse histories, resilience, positive self-esteem, and depressive 
symptoms. The predicted directions were unspecified due to inconsistencies in 
previous literature. The present study also explored whether depressive 
symptoms mediated any relationships between stress hormones and resilience, 
positive self-esteem, abuse histories, and CHD risk.  
Methods 
Participants and Procedure 
At the Chicago CORE center site of the Women's Interagency HIV Study 
(WIHS) 53 HIV+ women were recruited for participation in the current study 
during 2012. They were part of three WIHS enrollment waves (recruited 1994-
1995, 2001-2002 and 2011-2012). Barkan (1998) and Bacon and colleagues 
(2005) previously described study methods and baseline characteristics of WIHS 
participants.  Characteristics of the current sample were also described in studies 
1 and 2 and further below in the Results section.  Women were given informed 
consent forms before participation in the study and were provided with 
transportation support, childcare, and a financial honorarium of $25 for their time 
and effort. The study protocol was approved by Institutional Review Boards of 
Boston University and John H. Stroger Jr Hospital of Cook County as well as the 
WIHS Executive Committee.  
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Measures 
Domestic Violence, Physical Abuse, and Sexual Abuse Histories. 
Women were asked questions to capture any prior adult or childhood experience 
of sexual abuse, physical abuse and domestic violence at their baseline visit and 
then again each year over the course of their enrollment in WIHS (range 1-17 
years). Baseline questions began with “at any time in your life” and at annual 
study visits questions began with “since your (MONTH) study visit”. To assess for 
physical abuse, women were asked “Since your (MONTH) study visit, have you 
experienced serious physical violence (physical harm by another person)? By 
that I mean were you ever hurt by a person using an object or were you ever 
slapped, hit, punched, kicked?” To gather information on sexual abuse, women 
were asked “Since your (MONTH) study visit, has anyone pressured or forced 
you to have sexual contact? By sexual contact I mean them touching your sexual 
parts, you touching their sexual parts or sexual intercourse.” To obtain 
information on childhood sexual abuse, at baseline women were also asked the 
follow-up question, “How old were you when this first happened?” Childhood 
sexual abuse was coded as sexual abuse that occurred before age 18 years.  
For data on domestic violence, a total of seven questions were asked, such as 
“Since your (MONTH) study visit, has a current or previous partner threatened to 
hurt or kill you?” and “Since your (MONTH) study visit, has a current or previous 
prevented you from seeing friends?.” Summary variables were created to capture 
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the proportions of visits for which women reported current physical abuse, sexual 
abuse, domestic violence, and any abuse (physical, sexual, or domestic 
violence).  These proportions were created based on the number of visits over a 
18-year period in which women reported each type of abuse divided by the total 
number of visits.  
Connor-Davidson Resilience Scale -10 item (Campbell-Sills & Stein, 
2007). The 10-item CD-RISC captures adaptive coping strategies and personality 
traits that help an individual to strive in the face of or following adversity.  Items 
include, “ I am not easily discouraged by failure” and “ I believe I can achieve my 
goals, even if there are obstacles ”. Respondents rate items on a scale from 0 
(not true at all) to 4 (true nearly all the time). Higher scores reflect greater 
resilience and total scores on the scale range from 0 to 40. The CD-RISC 10 is 
an abbreviated and more stable version of the original 25 item CD RISC (Connor 
& Davidson, 2003) that has demonstrated good internal consistency (Cronbach’s 
α coefficient = .85) and construct validity. For instance, CD-RISC scores 
moderated the relationships between trauma exposure, childhood maltreatment, 
and psychiatric symptoms in the general population (Campbell-Sills & Stein, 
2007). The Cronbach’s alpha reliability coefficient was .91 in the current sample. 
Guided Autobiography Task and Qualitative Coding of Positive Self-
esteem. The Guided Autobiography task has been used extensively in previous 
research (D. P. McAdams et al., 2006).  The task requires women to tell 
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narratives about three key self-defining memories in the past 15 years that they 
considered to be turning points in their lives. The participants were asked to 
describe what happened in the event; when it happened; who was involved; and 
what they were thinking and feeling during the event. Positive self-esteem was 
defined as “an expression of positive attitudes, beliefs and/or insights about 
oneself including (but not limited to) personality, abilities, and accomplishments”. 
One word was the smallest unit of text that could be coded for positive self-
esteem (yes or no), but several words and/or sentences were often coded. For 
example, two participants were coded for positive self-esteem when they said 
“Me being one them really strong black woman” and “I just felt like I had a very 
nice personality”. The presence (scored 1) or absence (scored 0) of positive self-
esteem was made on the basis of coding across all three narratives provided by 
each participant. Coders were a fifth year PhD candidate in clinical psychology 
and an advanced undergraduate psychology student whose codes demonstrated 
moderate reliability for 34 participants using Pearson correlations (r=.51, p <.01). 
Coping strategies coded from narratives have been found to be sensitive to 
ethnic and cultural values and have been used in previous research with African 
American, Asian American, and low-income women (D. McAdams, 2006; D. P. 
McAdams et al., 2006; Wang & Conway, 2004). 
Coronary Heart Disease (CHD) risk measures. The composite 10 year 
Framingham CHD Risk score was used to assess overall CHD risk. The 
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Framingham Risk Score (FRS) (Wilson et al., 1998) is the gold standard for 
composite scoring methodology in cardiovascular research (Kannel & McGee, 
1987). Studies have found the FRS to be highly sensitive in predicting a 
diagnosis of coronary heart disease with sensitivity scores averaging around 
90% and specificity scores around 30% (Ketola, Laatikainen, & Vartiainen, 2009). 
There is also documentation of construct validity and predictive validity (Di Bari et 
al., 2004) in that FRS was able to accurately identify heart failure participants 
who had significantly greater abnormalities in cardiac structure and function (i.e. 
higher left ventricular mass index, lower ejection fraction, and higher left atrium 
systolic dimension) in comparison to non heart failure participants with 
significantly less abnormalities. FRS was also predictive of a higher heart failure 
related hospital admissions at follow-up. The FRS has been widely used in 
various populations including low-income, ethnic minority women (Matthews et 
al., 2005) as well as HIV positive populations (Knobel et al., 2007). The FRS 
composite score includes measures of systolic blood pressure, diastolic blood 
pressure, total blood cholesterol, high-density lipoprotein cholesterol, age, 
diabetes, and smoking.  These measures were collected via blood specimens 
and medical exams in the current visit.  
Collection of Urinary Cortisol and Norephinephrine. Cortisol and NE 
were assayed in urine that was collected in a 15-hour overnight period. To 
control for possible effects of menstrual cycle on hormone levels, urine collection 
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was done during the mid-follicular phase (5-10 days following first day of 
menses) of cycling women’s menstruation cycle and at any time for post-
menopausal women. Participants collected 15-hour overnight urine (random 
pooled sample) between 6pm and 9am or until their first morning void. A 15-hour 
overnight collection (6pm-9am) was chosen instead of a 24-hour collection 
because prior studies have reported better compliance with a 15-hour overnight 
urine collection. Night-time has been noted as the period most sensitive to 
chronic stress, and removes the confounding impact of activities such as work 
(Mellman, Kumar, Kulick-Bell, Kumar, & Nolan, 1995).  
Participants were given a) one 3-liter urine collection bottle that contained 
1 g of sodium metabisulfite preservative, b) an insulated grocery bag to be used 
for storing and transporting the urine, c) a plastic measuring cup that was used 
for urine collection and for easy pouring of urine into a collection bottle, d) a black 
marker to document urine collection start and end times, and e) a “reminder” 
posting that was placed on the toilet they used during the collection period. 
Participants were also asked to refrain for 12 hours prior to the evening urine 
collection from any intake of nicotine, alcohol, caffeine and diuretics. Participants 
delivered the urine collection to the clinic the morning of collection. The study 
research staff collected the urine, recorded the volume and refrigerated the urine 
until routine specimen collection by Rush Medical University labs in Chicago, IL 
the same or next day. Research staff also administered a questionnaire to collect 
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data on any medications taken (e.g. antidepressants, beta blockers, estrogen, 
diuretics, insulin, sedatives, pain medications, eye drops and nasal spray), 
substances used (e.g. alcohol, marijuana, crack, cocaine, and heroin), smoking 
(i.e. tobacco and cigarettes) and drinking of tea or coffee during collection. At 
Rush University Medical lab urine was spun and aliquots for stress hormones 
were acidified to a pH of 3 and frozen at 80°C (Freer, 1996) until shipped and 
assayed by Quest Nichols Specialty Lab in California. 
 Assay of Urinary Cortisol. Quest Nichols Specialty Lab used a liquid 
chromatography-tandem mass spectrometry (LC-MS/MS) method for urinary 
cortisol assay. With mean concentrations of 24.2-213.0 ug/L of cortisol, inter-
assay coefficients of variation were 6.0-9.4%. The cortisol levels were adjusted 
for urinary creatinine (a breakdown product of muscle creatine that is used as a 
measure of kidney function) by dividing cortisol concentrations (picomol) by 
creatinine concentration (micrograms of creatinine per liter of urine (mcg/g cr)). 
 Assay for Urinary Norephinephrine. Acidified urine was combined with 
ammonium acetate buffer and an internal standard compound, the combined 
mixture was poured over a micro-cation column and washed, and 
catecholamines were eluted from the columns.  The extract was then injected 
into a high-performance liquid chromatography with electrochemical detection. 
The sensitivity of the assay was 1.0 ng/ml and the intra-assay and inter-assay 
coefficients of variation were 4.8-6.5%. NE values were adjusted for creatinine by 
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dividing NE concentrations (picomol) by creatinine concentration (micrograms of 
creatinine per liter of urine (mcg/g cr)).  
Center for Epidemiological Studies Depression Scale (CES-D 
Scale)(Radloff, 1977). Previously described in the Methods section of study 1, 
the CES-D is a 21-item self-report measure of current affective depressive 
symptoms, which has been widely used among women with HIV.  
Data Analyses 
SPSS version 21.0 was used to conduct data analyses with Pearson 
correlations and hierarchical multiple linear regressions. Due to skewness and a 
few outliers cortisol and norepinephrine levels were log-10 transformed and used 
in subsequent analyses and a ratio of log-10 NE/ log-10 cortisol was derived. 
Analyses that included or deleted outliers yielded similar results so outliers were 
retained. Some participants were missing data on three measures. One 
participant declined to participate in the autobiographical narrative task, nine 
participants were missing norepinephrine levels because catecholamines were 
undetectable from their urine sample, and seven participants were missing the 
cholesterol data needed to compute CHD risk.  Missing data were not replaced.  
Results 
Sample Sociodemographics and Clinical Characteristics  
Fifty-three HIV+ women participated in the study the majority were women 
of color (86.8% African American and 3.8% Latinas) and did not complete high 
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school (64.2%). Their median annual household income was $6,001-$12,000. 
Proportions of visits in which women reported current abuse ranged between .00 
and .73 (minimum=0 and maximum=1) and are provided in Table 1. The average 
CD-RISC resilience score was 27.77 (7.50, range = 12 to 40); and 60.4% of the 
participants expressed positive self-esteem in autobiographical narratives. Mean 
CHD risk score was 3.96 (SD=6.45, range = -12 to 17), mean NE levels were 
24.26 mcg/g cr (SD=12.16, range = 10 to 73), and mean cortisol levels were 
21.58 mcg/g cr (SD=32.18, range = 2.2 to 225). Table 1 provides descriptive 
statistics on sociodemographic characteristics of the sample and all predictor and 
outcome variables.  
----------------------------------------------------- 
Insert Table 1 about here 
----------------------------------------------------- 
Preliminary Analyses 
Pearson correlations were conducted to assess relationships between the 
sociodemographic variables of age, income, education, and employment with all 
predictors and outcomes.  Results indicated that a few significant associations 
and trends existed. Higher CHD risk was significantly positively correlated with 
being older (r=.61, p=.001) and unemployed (r= -.34, p=.03).  Being younger was 
significantly positively associated with a higher proportion of visits in which 
domestic violence was reported (r=-.31, p=.03) and tended to be positively 
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related to higher proportions of reporting current physical violence at visits (r=-
.27, p=.06). Higher resilience tended to relate to higher education (r=.25, p=.08); 
higher positive self-esteem tended to relate to higher income (r=.27, p=.06) and 
being older (r=.27, p=.06); and higher depressive symptoms significantly related 
to lower education (r= -.30, p=.03) and tended to relate to lower income (r= -.25, 
p=.08).  These sociodemographic variables were controlled in all relevant 
regression analyses.  
 In responding to the post urine collection questionnaire, three participants 
(5.7%) reported using crack, cocaine or heroin and their data were excluded from 
analyses with cortisol and NE given the fact that these substances may raise 
stress hormone levels (Haile, Mahoney, Newton, & De La Garza, 2012; Heesch 
et al., 1995; Kreek, 1996). Two women reported taking beta blockers (4%) and 
because taking beta blockers significantly related to a lower NE/cortisol ratio (r=-
.32, p=.05), it was entered as a covariate in all NE/cortisol analyses. A lifetime 
history of ever using crack/cocaine/heroin was significantly associated with 
higher levels of cortisol (r= .37, p=.008) and was also controlled in all analyses 
that included cortisol and NE/cortisol ratio as variables.  
 Pearson correlations among proportions of visits at which sexual abuse, 
physical abuse, domestic violence, and any abuse occurred revealed that sexual 
abuse significantly positively related to physical violence (r=.63, p=.001) and 
domestic violence (r=.72, p=.001), and domestic violence and physical violence 
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significantly positively related to each other (r=.89, p=.001) . Resilience and 
positive self-esteem approached significance in positively correlating with each 
other (r=.25, p=.07).  
----------------------------------------------------- 
Insert Table 2 about here 
----------------------------------------------------- 
Hypothesis 1:  Abuse Histories and CHD Risk  
With age and employment status as covariates, partial correlations were 
conducted to test the hypothesis that abuse histories would significantly relate to 
higher CHD risk.  The hypothesis was supported in that proportions of visits in 
which current sexual abuse (r=.29, p=.03), physical abuse (r=.42, p=.002),  
domestic violence (r=.35, p=.01), and any abuse (Beta=.38, p=.007) were 
reported were all significantly positively correlated with higher CHD risk 
composite score.   
Hypothesis 2a: Abuse Histories, Resilience, and Positive Self-esteem 
Partial correlations were conducted to test the hypothesis that abuse 
histories would significantly relate to lower levels of resilience and positive self-
esteem, controlling for covariates (age and income in partial correlation in which 
positive self-esteem was an outcome; and age, education, and employment in 
resilience partial correlation).  Analyses only tended to support the hypothesis in 
that a higher proportion of visits where current physical abuse was reported 
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tended to negatively relate to positive self-esteem (r= -.21, p= .07). Visit 
proportions of current sexual abuse, domestic violence, and any abuse were not 
significantly related to positive self-esteem and no abuse histories were 
significantly associated with resilience.  
Hypothesis 2b:  Resilience, Positive Self-esteem, and CHD risk  
Partial correlations of resilience and positive self-esteem with the CHD risk 
score, and covariates of age, employment, education (in partial correlation in 
which resilience was an outcome) and income (in partial correlation in which 
positive self-esteem was an outcome) were used to test the hypothesis that 
higher resilience and positive self-esteem would relate to lower CHD risk.  
Results only tended to support the hypothesis in that higher positive self-esteem 
tended to be related to lower CHD risk (r= -.23, p= .08).  Resilience did not 
significantly relate to CHD risk.  
Hypothesis 3: Depressive symptoms in Relation to Resilience, Positive 
self-esteem, Abuse Histories, and CHD risk 
To test the hypothesis that higher depressive symptoms would be associated 
with lower resilience, lower positive self-esteem, abuse histories, and higher 
CHD risk, partial correlations were conducted controlling for age, employment 
status, education, and income. In partial support of the hypothesis, higher 
depressive symptoms were significantly related to lower resilience (r= -.35, p= 
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.007). However, inconsistent with the hypothesis, depressive symptoms were not 
significantly associated with positive self-esteem, abuse histories or CHD risk.  
Hypothesis 4: Depressive symptoms mediating the relationships between 
Resilience, Positive Self-esteem, and Abuse Histories with CHD risk 
Three prerequisite conditions have to be met to suggest existence of a mediation 
(Holmbeck, 1998) (1) predictor (i.e. resilience, positive self-esteem, or abuse 
histories) significantly relates to the outcome (CHD risk), (2) predictor 
significantly relates to the potential mediator (depressive symptoms), and (3) the 
mediator significantly relates to the outcome. Conditions were not met to suggest 
that depressive symptoms mediated the relationships of CHD risk with resilience, 
positive self-esteem, and abuse, because although depressive symptoms 
significantly related to resilience, depressive symptoms were not significantly 
associated with CHD risk, abuse histories, and positive self-esteem. Thus 
depressive symptoms did not mediate relationships of CHD risk with resilience, 
positive self-esteem, and abuse histories.  
Exploratory Question: Abuse Histories and Stress Hormones 
To examine whether abuse histories were associated with total levels of 
urinary cortisol, norepinephrine, or NE/cortisol ratio, partial correlations were run 
while controlling for covariates that related to abuse histories (i.e. age) and 
hormone levels in this sample (i.e. lifetime use of crack/cocaine/heroin in a partial 
correlation in which cortisol was an outcome, and beta blockers and lifetime use 
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of crack/cocaine/heroin in a partial correlation in which NE/cortisol was an 
outcome). Results indicated that a higher proportion of visits in which current 
sexual abuse (r=.22, p=.09), any abuse (r=.25, p=.07) and physical abuse (r=.19, 
p=.12) were reported approached significance in relating to higher 
norepinephrine levels. Abuse histories were not significantly associated with 
levels of cortisol or NE/cortisol ratio. 
Exploratory Question: Stress Hormones and CHD Risk  
Using partial correlations we examined whether cortisol, norepinephrine, 
or NE/cortisol ratio significantly related to CHD risk with covariates of age, 
employment status, and substance use (i.e. lifetime use of crack/cocaine/heroin 
in a partial correlation in which cortisol was an outcome, and beta blockers and 
lifetime use of crack/cocaine/heroin in a partial correlation in which NE/cortisol 
was an outcome).  Higher cortisol significantly negatively correlated with CHD 
risk score (r= -.56, p= .001). In contrast, higher NE/cortisol ratio significantly 
positively related to CHD risk score  (r= .42, p= .008). NE alone was not 
associated with CHD risk score.  
Exploratory Question: Resilience, Positive Self-esteem, and Stress 
Hormones  
One of the primary aims of this study was to test whether resilience and 
positive self-esteem related to total levels of cortisol, norepinephrine, and 
NE/cortisol ratio.  We ran partial correlations of resilience with positive self-
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esteem and stress hormones controlling for sociodemographics. Education and 
employment were controlled in partial correlations in which resilience was an 
outcome. Income and age were controlled in partial correlations in which positive 
self-esteem was an outcome. In addition, substance use was controlled in 
several partial correlations (lifetime use of crack/cocaine/heroin in partial 
correlations in which cortisol was an outcome, and beta blockers and lifetime use 
of crack/cocaine/heroin in partial correlations in which NE/cortisol was an 
outcome). Results indicated that resilience significantly negatively related to 
cortisol levels (r= -.29, p= .03) and approached significance in negatively relating 
to NE (r= -23, p= .08), but was not associated with NE/cortisol ratio. In addition, 
positive self-esteem significantly negatively related to NE (r= -.29, p= .04), but 
was not associated with cortisol or the NE/cortisol ratio.  
Exploratory Question: Depressive Symptoms and Stress Hormones  
The present also explored the relationships between depressive 
symptoms with total levels of cortisol, norepinephrine, and NE/cortisol ratio using 
partial correlations that controlled for income, education, and substance use 
(lifetime use of crack/cocaine/heroin in partial correlations in which cortisol was 
an outcome, and beta blockers and lifetime use of crack/cocaine/heroin in partial 
correlations in which NE/cortisol was an outcome). Findings revealed that 
depressive symptoms did not significantly relate to total levels of cortisol, 
norepinephrine, and NE/cortisol ratio.  
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Exploratory Question: Depressive Symptoms Mediating Relationships 
among Resilience, Positive Self-esteem, Stress Hormones and CHD risk 
Prerequisite conditions (Holmbeck, 1998) were not satisfied to explore 
whether depressive symptoms mediated any relationships between resilience 
and positive self-esteem with stress hormones, between stress hormones and 
CHD risk. The present study showed that resilience significantly and inversely 
related to depressive symptoms, however depressive symptoms did not 
significantly relate to the outcomes (i.e. stress hormones and CHD risk) or one of 
the predictors (i.e. positive self-esteem).  Therefore depressive symptoms did not 
mediate any relationships among resilience, positive self-esteem, stress 
hormones, and CHD risk.  
Discussion 
Our findings indicate that in women with HIV, resilience was significantly 
associated with lower cortisol levels and tended to relate to lower NE levels and 
positive self-esteem was significantly related to lower NE levels.  The relationship 
between resilience and cortisol levels corroborates findings by other researchers 
that problem-engaging coping and personal mastery were associated with lower 
cortisol levels (O'Donnell, Badrick, Kumari, & Steptoe, 2008; Vedhara et al., 
2006).  The relationships found between positive self-esteem and higher 
resilience with lower norepinephrine levels add to previous findings that higher 
self-efficacy was associated with lower NE levels and that decreased action 
	  	  
	  
	  
91 
oriented coping overtime was also related to higher NE levels (Bandura, Taylor, 
Williams, Mefford, & Barchas, 1985; Kilbourn, 1997). 
Stress Hormones, CHD Risk, and Abuse Histories  
 CHD risk was significantly related to higher NE/cortisol ratio as well as to 
higher cortisol levels.  The relationship between CHD risk and NE/cortisol ratio is 
a new contribution to the literature and is in accordance with studies that have 
linked high norepinephrine levels and low cortisol levels (measured 
independently) with heart disease (Bennett et al., 2004; Zoccali et al., 2002). In 
addition, the present study’s finding that higher cortisol levels significantly 
predicted lower CHD risk score supports previous literature noting the anti-
inflammatory benefits of cortisol (Fantidis et al., 2002; Straub et al., 2002).  In 
contrast, many other studies have noted the seemingly opposite finding: that 
higher, not lower, cortisol levels relate to negative cardiovascular consequences 
(Vogelzangs et al., 2010; Whitworth, Williamson, Mangos, & Kelly, 2005). These 
results together (a) emphasize that both high and low levels of stress hormones 
can be indicative of HPA dysregulation and relate to risk for CHD and (b) suggest 
that the ratio of NE/cortisol may be a useful clinical marker of CHD risk.  This is 
similar to the noted sensitivity of the NE/cortisol ratio in distinguishing between 
PTSD and non-PTSD diagnoses: patients with PTSD had a higher NE/cortisol 
ratio than patients without PTSD (Mason et al., 1988). 
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 Higher proportions of visits in which current sexual abuse, physical abuse 
and any abuse were reported approached significance in relating to higher NE 
levels and this is consistent with previous literature that found higher NE levels 
among individuals with PTSD compared to those without (Geracioti et al., 2001). 
However, in the present study, abuse histories were not significantly associated 
with levels of cortisol or NE/cortisol ratio. Previous literature has indicated that 
trauma/abuse histories have been associated with higher norepinephrine and 
lower cortisol levels as well as higher cortisol (following exposure to reminders of 
previous traumas) (Elzinga, Schmahl, Vermetten, van Dyck, & Bremner, 2003; 
Mason et al., 1988; Yehuda et al., 2001; Yehuda et al., 1995). Perhaps the 
complexity of the HPA as reflected by the inconsistencies in the literature in 
combination with our relatively small sample size impacted our null findings 
between abuse histories and cortisol and NE/cortisol ratio.   
 
CHD risk, Resilience, Positive Self-esteem, and Abuse Histories 
 Positive self-esteem also approached significance in relating to lower CHD 
risk, a finding that is similar to previous findings that adolescents with severe 
heart disease reported lower self-esteem in comparison to adolescents with mild 
heart disease. The finding that CD-RISC resilience did not relate to CHD risk is in 
contrast to studies that found that higher ego resilience and higher 
hardiness/resilience were associated with lower risk factors for CHD (i.e. low 
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blood pressure and high HDL cholesterol) (P.T. Bartone et al., 2009; J. H. Block 
& Block, 1980).  However, none of these studies used the CD-RISC scale to 
measure resilience and there was a difference in how ego resilience and 
hardiness were defined/ conceptualized in comparison to self-reported resilience.  
In the study by Block and colleagues (1996; 1980) ego resilience was defined as 
the capacity to modify impulse expression based on contextual factors and was 
measured by the Ego Resilience Scale and Bartone and colleagues captured 
hardiness with the Dispositional Resilience Scale (2007; 2009).   
 A higher proportion of visits in which women reported abuses (sexual, 
physical, domestic violence, and any abuse) were significantly related to higher 
CHD risk, and these relationships confirm the limited number of previous findings 
that have linked histories of abuse with risk for heart disease (Dong et al., 2004; 
Midei et al., 2013) and add to this body of literature.  Abuse histories may lead to 
increased heart disease risk by the way of consequences of abuse such as 
obesity and substance use that are noted risk factors for heart disease as well as 
via elevated levels of stress hormones. As noted above, abuse histories showed 
a trend of relating to higher norepinephrine and higher NE/cortisol ratio was 
related to higher CHD risk.     
A higher proportion of visits in which current physical abuse was reported 
tended to relate to lower positive self-esteem, but proportions of current domestic 
violence, sexual abuse, and any abuse were not significantly related to positive 
	  	  
	  
	  
94 
self-esteem. These results are puzzling, but perhaps physical abuse is especially 
damaging to the development of self-esteem, or perhaps we were limited by our 
small sample size in detecting significant relationships between other types of 
abuse and self-esteem. Similarly, sexual abuse, physical abuse, and domestic 
violence (measured as proportion of visits for which each were reported) were 
not significantly associated with resilience. This corroborates previous studies 
using the CD-RISC scale to measure resilience, which also did not report a 
significant relationship between abuse/trauma and resilience (Campbell-Sills & 
Stein, 2007; Wingo et al., 2010).    
 CD-RISC resilience and positive self-esteem tended to be positively 
associated with each other. However, as noted they were each related to other 
variables somewhat differently (e.g. higher CD-RISC resilience alone related to 
lower cortisol and only positive self-esteem showed a trend of relating to lower 
CHD risk), which was not necessarily unexpected given that they used different 
assessment methods. Positive self-esteem was assessed qualitatively from 
autobiographically narratives and CD-RISC resilience scale is a quantitative 
measure that captures adaptive personality traits and coping strategies (e.g. “I try 
to see the humorous side of things when I am faced with problems”). However, 
both measures may relate to each other because CD-RISC resilience has a few 
items that touch on how the women view themselves (e.g. “ I am able to adapt 
when changes occur” and “I am not easily discouraged by failures”).   
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Depressive Symptoms, Abuse Histories, Resilience, Positive Self-esteem, 
Stress Hormones and CHD Risk 
Depressive symptoms were investigated in relation to the primary 
variables of interest in the current study (i.e. abuse histories, resilience, positive 
self-esteem, stress hormones and CHD risk) and also as a potential mediator of 
the relationships among the variables. However, inconsistent with the literature, 
depressive symptoms were not significantly related to abuse histories and 
positive self-esteem (Boudewyn & Liem, 1995; Butler et al., 1994; Franck & De 
Raedt, 2007; Hegarty et al., 2004). The finding that positive self-esteem did not 
relate to depressive symptoms may be because the stability of self-esteem is 
more predictive of depression than are levels of self-esteem (Franck & De Raedt, 
2007). Similarly, depressive symptoms were not associated with CHD risk and 
these findings were also inconsistent with literature showing that depression is 
related to increased risk for CHD and cardiac mortality (Khawaja et al., 2009). 
Perhaps these null findings were due to limited power of the analyses in 
detecting significant relationships because of the small sample size.  In addition, 
depressive symptoms were not significantly associated with stress hormones 
levels, a finding that is not surprising given the inconsistencies in literature, with 
studies noting both higher and lower cortisol levels and higher norepinephrine 
levels in relation to depressive symptoms (2007; Burke et al., 2005; Hughes et 
al., 2004; Knight et al., 2010; Otte et al., 2005). 
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Conclusion  
With effective medications, HIV + women have increased life 
expectancies, but are at increased risk for heart disease, especially women with 
histories of abuse. In a sample of HIV+ women this study presents new findings 
that (a) resilience significantly related to lower cortisol levels and tended to relate 
to lower norepinephrine levels (b) positive self-esteem significantly related to 
lower norepinephrine levels (c) a higher NE/cortisol ratio relates to higher CHD 
risk and (d) positive self-esteem approached significance in relating to lower 
heart disease risk. Our findings also confirmed existing literature in that histories 
of abuse significantly related to higher CHD risk and approached significance in 
relating to lower positive self-esteem and higher norepinephrine; and that lower 
urinary cortisol levels are significantly associated with higher CHD risk. These 
results suggest that resilience and positive self-esteem may be important 
psychological factors to target in interventions in order to lessen the negative 
impact of stress hormones and abuse histories on the cardiovascular health of 
women with HIV.  
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Table 4.1  Sample characteristics and socio-demographic  
statistics of hormone sub-study participants.  
Characteristics  Mean (SD) 
 Age 48.33 (8.92) 
Resilience (CD-RISC) 27.77 (7.50) 
Proportion of current domestic 
violence  .07 (.13) 
Proportion of current physical abuse .05 (.11) 
Proportion of current sexual abuse .03 (.11) 
Proportion of any abuse  .09 (.16) 
CHD risk score   4.21 (6.35) 
Cortisol (mcg/g cr) 21.58 (32.19) 
Norepinephrine (mcg/g cr) 24.26 (12.16) 
Depressive Symptoms (CES-D) 13.75 (9.51) 
 
 n (%) 
Positive Self-esteem  32 (60.4) 
Race 
   White / non-Hispanic 3 (5.7) 
   White / Hispanic 2 (3.8) 
   African-American / non- Hispanic 46 (86.8) 
   Other / Hispanic 1 (1.9) 
   Other  1 (1.9) 
Education  
   Grade 11 or less 22 (41.5) 
   Completed high school 19 (35.8) 
   Some college  11 (20.8) 
   Attended/completed graduate    
   School 1 (1.9) 
Income  
   $6,000 or less 15 (28.3) 
   $6,001-$12,000 24 (45.3) 
   $12,001 or more 14 (26.4) 
Unemployed  46 (86.8) 
Marital Status  
Legally/common- law marriage  3 (5.7) 
  Not married but living w partner 2 (3.8) 
   Widowed 7 (13.2) 
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   Divorced/Annulled 8 (15.1) 
   Separated 6 (11.3) 
   Never married 27 50.9) 
Note. CD-RISC= Connor Davidson Resilience Scale (10-item); 
CHD= Coronary Heart Disease; and Mcg/g cr = Micrograms of 
creatinine per liter of urine. 
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Table 4.2 Partial correlations among Resilience, positive self-esteem, abuse 
histories, depressive symptoms, stress hormones and coronary heart 
disease risk 
 
 
Variable 1 2 3 4 5 6 7 8 9 10 11 
1.Resilience 
(CD-RISC) a - .25t .01 .05 .10 .05 .29* -.23t .09 .16 -.36** 
2. Positive 
Self-esteemb  -- .10 -.21t -.10 -.15 -.02 -.29* .01 -.23t -.16 
3. Proportion 
of current 
domestic 
violencec   -- .89*** .72*** .92*** .06 .10 -.05 .35** .11 
4. Proportion 
of current 
physical 
abusec    -- .63*** .88*** -.03 .19 .03 .42** .15 
5. Proportion 
of current 
sexual 
abusec     -- .82*** .16 .22t -.12 .29* .08 
6. Proportion 
of any 
abusec      -- .07 .25 t -.04 .38** 
 
.17 
7. Cortisol 
log10 
transformed 
(mcg/g 
creatinine)d       -- .09 -.81*** -.56*** .14 
8.Norepine-
phrine log10 
transformed 
(mcg/g 
       -- .12 .16 .14 
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creatinine) 
9.NE/Cortisol 
Ratioe         -- .43** .08 
10. CHD risk 
scoref          -- -.03 
11.Depress- 
ive 
Symptoms  
(CES-D) g           -- 
Note. All tests are one-tailed. Covariates differed by analyses and are noted below.  
CD-RISC= Connor Davidson Resilience Scale (10-item); NE = Norepinephrine; and 
CHD= Coronary Heart Disease risk score computed based on the Framingham Risk 
Score guidelines. 
*p < .05. **p < .01. ***p < .001. tp < .10. 
aAnalyses controlled for age, education, and income  
bAnalyses controlled for age and income  
cAnalyses controlled for age 
dAnalyses controlled for lifetime history of crack/cocaine/heroin 
eAnalyses controlled for beta blockers and lifetime history of crack/cocaine/heroin 
fAnalyses controlled for age and employment 
gAnalyses controlled for income and education 
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CHAPTER FIVE 
General Discussion 
Literature on women with HIV has often focused solely on factors that 
place women “at risk” for poor health outcomes such as abuse/trauma, with only 
a limited number of studies investigating the positive psychosocial factors that 
may buffer the negative effects of abuse.  Resilience is especially important 
among Black women, who account for over 60% of women with HIV and are 
faced with many environmental and societal stressors, such as racism, sexism, 
poverty and unstable neighborhoods.  However, very few studies have looked at 
how resilience relates to health outcomes in a sample of women who are 
primarily Black and have HIV or who are at risk for HIV (Centers for Disease 
Control and Prevention, 2013b; Faison, 2007; Norman, 2002; Singleton, 2004).   
In the current project, a series of three studies of women with and at risk 
for HIV investigated relationships among abuse and mental and physical health 
outcomes as moderated by stress hormones, resilience, and positive self-
esteem. The sample was primarily Black women with a small number of Latina 
and White women.  Physical health outcomes were both non-HIV specific (CHD 
risk) and HIV specific (CD4 cell count and viral load) and mental health outcomes 
included depressive symptoms and quality of life.  Specifically, the study 
analyzed if: (a) in both HIV+ and HIV- women, higher resilience related to lower 
depressive symptoms and higher health-related quality of life (HRQOL), and  (b) 
	  	  
	  
	  
102 
among HIV+ women if resilience related to better health outcomes, including 
highly active antiretroviral (HAART) medication adherence, HIV viral load, CD4 
cell count, stress hormones (i.e. norepinephrine and cortisol), and coronary heart 
disease risk (CHD), (c) whether depressive symptoms mediated relationships 
between resilience and the noted health outcomes, and (d) whether resilience 
moderated the relationships between histories of abuse/trauma and health 
outcomes, such that only for women scoring low on resilience would abuse relate 
to worse health outcomes.  
 Study 1 consisted of a sample of 138 HIV+ women and 64 HIV- 
sociodemograhically matched women and examined the relationships among 
resilience, childhood sexual abuse (CSA), depressive symptoms, and HRQOL 
and whether resilience moderated the relationships between CSA and outcomes. 
Study 2 focused exclusively on 138 HIV+ women and investigated the 
relationships among resilience, abuse histories, HAART adherence, HIV viral 
load, and CD4 cell count and examined if resilience moderated the relationships 
between abuse histories and HIV health outcomes as well as whether depressive 
symptoms mediated relationships of resilience with HAART adherence, HIV viral 
load, and CD4 cell count. Study 3 also focused on HIV+ women to investigate the 
relationships among resilience, positive self-esteem, abuse histories, stress 
hormones, and CHD risk among 53 HIV+ women; and investigated depressive 
symptoms as a potential mediator of these relationships. In all studies it was 
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hypothesized that resilience (and positive self-esteem in study 3) would buffer 
the impact of abuse histories and relate to better health outcomes, and in study 
3, would relate to less dysregulated stress hormones.  
Summary of Results 
In accordance with hypotheses, studies 1 to 3 demonstrated that higher 
levels of resilience related to better health outcomes for both women with and at 
risk for HIV.  Resilience also moderated the relationships between histories of 
abuse and health outcomes, so that only for women scoring low on resilience did 
abuse relate to worse health outcomes. Resilience and positive self-esteem also 
related to lower stress hormone levels, which in turn related to a lower likelihood 
of a history of abuse and related to CHD risk in complex ways. These results 
consist of both novel findings that add to the literature as well as findings that 
corroborate existing literature.  
Resilience and Mental and Physical Health Outcomes 
In study 1, higher resilience significantly related to lower depressive 
symptoms and higher health related quality of life across both HIV+ and HIV-
women, and resilience moderated the relationship between a history of childhood 
sexual abuse and depressive symptoms, so that only for women scoring low in 
resilience did abuse significantly relate to depression.  Although this finding was 
supported by previous studies in community samples (Campbell-Sills & Stein, 
2007; Wingo et al., 2010) this moderation finding has never been reported 
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among a sample of HIV+ and HIV- women. However, resilience as a moderator 
between childhood sexual abuse and depressive symptoms is especially relevant 
in the current sample given the extremely high prevalence of abuse histories and 
the link between abuse with higher depressive symptoms. Furthermore, higher 
depressive symptoms have been linked to other health outcomes for women with 
HIV such as medication nonadherence and mortality (M. Cohen et al., 2000; M. 
H. Cohen et al., 2004; Machtinger, Haberer, et al., 2012).  Study 1 also found 
that higher resilience relates to lower depressive symptoms and better health-
related quality of life, which is in accordance with studies among HIV infected 
individuals by Yu et al (2009b) and Farber et al. (2000) who that found that lower 
resilience was associated with higher depressive symptoms and hardiness (a 
construct similar to resilience) was related to lower psychological distress and 
higher physical health quality of life. 
Study 2 revealed that among HIV+ women, resilience significantly related 
to having undetectable VL and resilience also moderated the relationship 
between sexual and multiple abuse histories and lower HAART adherence, so 
that only for women scoring low in resilience did abuse relate to lower HAART 
adherence. This is the first study to report that resilience was significantly 
associated with having undetectable HIV VL and that resilience moderated the 
relationship between abuse histories and HAART adherence so that sexual and 
multiple abuse histories related to lower HAART adherence only for women 
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scoring low in resilience. These findings are also consistent with previous studies 
reporting that positive psychological factors including conscientiousness  (e.g., 
being organized, detail oriented and responsible), finding meaning in challenging 
circumstances, and being optimistic were related to higher medication 
adherence, lower HIV viral load, and lower HIV mortality (Ickovics et al., 2006; 
O'Cleirigh et al., 2007). In addition, Study 2 confirmed prior study findings that 
higher depressive symptoms are associated with lower HAART adherence.  
However, depressive symptoms did not mediate the relationship between 
resilience and HAART adherence, indicating that resilience does not influence 
HAART adherence via its effect on depressive symptoms.  
Study 3 demonstrated that among HIV+ women, higher resilience related 
to lower cortisol levels; and higher PSE related to lower NE levels. Study 3 also 
indicated that higher CHD risk related to higher NE/cortisol ratio, lower cortisol 
levels, and histories of abuse.  Higher resilience significantly relating to lower 
cortisol and higher positive self-esteem relating to lower norepinephrine are novel 
findings.  These findings are supported by previous literature noting that problem-
engaging coping and personal mastery were associated with lower cortisol levels 
(O'Donnell et al., 2008; Vedhara et al., 2006), that high self-efficacy was 
associated with lower NE and that decreased action oriented coping overtime 
was related to higher NE (Bandura et al., 1985; Kilbourn, 1997). Study 3 also 
found that higher histories of abuse related to higher CHD risk, NE/cortisol ratio 
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related to higher CHD risk, and lower cortisol related to higher CHD risk. Only a 
limited number of studies have reported an association between histories of 
abuse and heart disease risk for women (Midei et al., 2013) and none have been 
in samples of HIV+ women who may be at increased risk for heart disease 
(Barbaro, 2003; Currier et al., 2003). In addition, while NE/cortisol ratio has been 
noted as sensitive in differentiating people who meet diagnostic criteria for post-
traumatic disorder (higher NE/cortisol ratio) and those who do not (Mason et al., 
1988), and PTSD has been associated with heart disease mortality among 
veterans (Boscarino, 2008), no previous study has linked a high NE/cortisol ratio 
with coronary heart disease risk.  Perhaps NE/cortisol ratio may serve as a 
mediator between PTSD and heart disease. The finding that lower cortisol was 
associated with higher CHD risk may be related to previous findings on the anti-
inflammatory benefits of cortisol.  At low cortisol levels, anti-inflammatory benefits 
may be diminished (Fantidis et al., 2002; Straub et al., 2002).  However, there 
are inconsistencies in the previous literature in that both higher and lower levels 
of cortisol been linked to heart disease (Cohn et al., 1984; Fantidis et al., 2002; 
Otte et al., 2007; Smith et al., 2005; Straub et al., 2002; Vogelzangs et al., 2010).  
Across all three studies resilience was measured using the CD-RISC, a 
self-report scale which captures personal qualities and adaptive coping strategies 
including humor, persistence, being able to adapt to change, and believing in 
one’s ability to surpass obstacles (Campbell-Sills & Stein, 2007; Connor & 
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Davidson, 2003). There are several possible explanations for the major findings 
that (1) higher resilience was related to lower depressive symptoms, higher 
health related quality of life, undetectable viral load, and lower stress hormones 
and that (2) resilience moderated the relationships between abuse histories and 
health outcomes so that abuse predicted nonadherence and depressive 
symptoms only for women scoring low in resilience, but not for women high in 
resilience.  
First, women who scored high on resilience may have utilized adaptive 
coping strategies (e.g. seeking out treatment or resources and believing “I can 
deal with whatever comes my way” (item 2 of CD-RISC)) that made them either 
less likely to develop depressive symptoms or more likely to recover. Second, 
women scoring high in resilience may have also endorsed lower depressive 
symptoms and a higher health-related quality of life because being less 
depressed and more positive is consistent with a resilient self-identity, as 
captured in item 9 on the CD-RISC,  “I think of myself as a strong person when 
dealing with life’s challenges and difficulties”.  Third, women scoring high on 
resilience may also engage in more health promoting behaviors such as eating 
healthy foods, exercising, attending doctors appointments, and adhering to 
prescribed medications. Fourth, women who scored high on resilience may 
conceptualize successful management of their HIV and of having undetectable 
viral loads as goals and they work towards achieving those goals by adhering to 
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their medications consistently. Fifth, high resilience may act as a buffer between 
histories of abuse with depression and HAART adherence. Women who both 
have a history of abuse and also score high on resilience may view HIV as yet 
another hardship that they can bounce back from, given that they survived and 
bounced back following abuse, i.e. their previous experiences have given them 
the courage to feel that they can overcome adversity. Having this view may have 
buffered against the negative influence of abuse and translated into lower 
depressive symptoms, and more consistent adherence to their medications. It 
may also be that resilience buffers negative health outcomes by affecting levels 
of stress hormones, as study 3 showed that resilience related to lower cortisol 
levels. For instance, studies have found higher levels of cortisol among 
individuals diagnosed with depression and suggest that high cortisol may induce 
depression (Herbert, 2013). However, there have been some inconsistencies 
with other studies not reporting elevated cortisol in individuals with depression 
(Cowen, 2002; Strickland et al., 2002), similar to our findings that there was not a 
significant relationship between depressive symptoms and stress hormones in 
study 3. Nonetheless the literature that has noted higher cortisol levels among 
individuals with depression suggests that the relationship between resilience and 
lower cortisol may explain, or account for, the association between resilience and 
lower depressive symptoms.  
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The links between resilience and positive self-esteem with levels of 
cortisol and norepinephrine also support the growing field of 
psychoneuroimmunology, which posits reciprocal relationships between 
psychological factors and neural and immune functioning (Gidron, Gilutz, Berger, 
& Huleihel, 2002; Maier, Watkins, & Fleshner, 1994). Perhaps women scoring 
high in resilience had lower urinary output levels of stress hormones cortisol and 
norepinephrine, because they utilized adaptive coping strategies when faced with 
stressors and therefore stressors such as abuse did not result in dysregulation of 
their stress hormone levels. Additionally both stress hormone levels and personal 
characteristics such as extraversion and sociability have been linked to genetics 
(Kim et al., 2011; Velders et al., 2011; Weiss, Bates, & Luciano, 2008) so 
perhaps (a) the women who inherited adaptive traits also inherited genes 
associated with lower stress hormones (or were not exposed to prenatal 
conditions linked with higher cortisol, such as smoking)(Schuetze, Lopez, 
Granger, & Eiden, 2008), which placed them in a position to have better health 
outcomes or (b) women who were biologically predisposed to have lower stress 
hormones also grew up in an environment that may have been more nurturing 
and helped them to develop adaptive coping strategies.  
Positive self-esteem was also related to lower norepinephrine levels and 
tended to relate to lower coronary heart disease. Perhaps individuals with 
positive self-esteem do not react strongly to stressors (especially those that are 
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in conflict with their beliefs about themselves) because they have a positive view 
of themselves. Positive esteem has been related to positive thinking and 
optimism (Caprara, Steca, Gerbino, Paciello, & Vecchio, 2006; Mäkikangas, 
Kinnunen, & Feldt, 2004) thus women with high positive esteem may regulate 
their stress response with adaptive strategies such as using alternative positive 
thoughts (e.g. “I am strong”) to counteract negative thoughts.  These strategies 
may prevent their NE levels from becoming dysregulated. There is a great deal of 
evidence in the cognitive- behavioral therapy literature to support the idea that 
cognitively reframing negative thoughts into positive ones is beneficial in 
regulating distress (Barlow, Allen, & Choate, 2004). Positive esteem by way of 
positive thinking might therefore relate to women’s lower stress hormones, which 
may in turn relate to their lower risk for CHD risk as evidenced by the finding 
showing that lower NE/cortisol ratio is related to lower CHD risk from study #3.   
CHD risk was assessed using the Framingham Risk Score, which is a 
composite score of measures of blood pressure, cholesterol, and smoking.  
Previous literature has indicated that elevated blood pressure is related to both 
high norepinephrine and high cortisol levels (Masuo, Kawaguchi, Mikami, 
Ogihara, & Tuck, 2003; Whitworth et al., 2005).  Thus, women with positive self-
esteem might have lower stress hormones, which in turn might relate to lower 
blood pressure and therefore lower CHD risk as evidenced by study 3.  In 
addition, if women with positive self-esteem engage in adaptive coping strategies 
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in lieu of maladaptive coping such as smoking this would also lower their CHD 
risk score.   
Depressive Symptoms in Relation to Abuse Histories, Positive Self-esteem, 
Stress Hormones, and CHD Risk 
Depressive symptoms were not significantly associated with abuse 
histories, positive self-esteem, stress hormones, and CHD risk; and therefore 
was not a significantly mediator of relationships among these variables or 
between resilience and these variables. These null findings were somewhat 
surprising given that higher depressive symptoms have been linked with abuse 
histories, low self-esteem, dysregulated levels of stress hormones, and increased 
CHD risk (2007; Kernis et al., 1991).  However these null findings may be 
attributed to or explained in the context of several issues.  First, while prior 
literature has linked abuse histories with higher depressive symptoms, this 
relationship has sometimes been moderated by other variables. This was 
demonstrated in study 1, in which childhood sexual abuse was associated only 
with higher depressive symptoms for women low in resilience. Thus, in the 
current studies we may not have tested variables that may have been significant 
moderators of relationships between depressive symptoms and other variables. 
Second, positive self-esteem may not have been related to depressive symptoms 
because previous studies investigating self-esteem utilized quantitative 
measures of self-esteem and in the current research, autobiographical narratives 
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were used to rate the presence or absence of positive self-esteem (Kernis et al., 
1991; Orth et al., 2008). Third, a lack of association between depressive 
symptoms with cortisol, norepinephrine, and the cortisol/NE ratio is not surprising 
because associations between depressive symptoms and stress hormones have 
been inconsistent in the literature.  Studies have noted that both higher and lower 
levels of stress hormones are related to depressive symptoms (2007; Burke et 
al., 2005; Otte et al., 2005). Fourth, the absence of significant findings between 
depressive symptoms and CHD risk may have been due to the relatively small 
sample size in study 3. The small sample size may also have accounted for other 
null findings regarding the relationship between depressive symptoms and other 
variables.  
Strengths and Limitations of the Present Studies 
 Overall the findings from these three studies make novel contributions to 
the literature about the relationships among resilience, abuse, and health 
outcomes among women with and at risk for HIV. However, these findings may 
have been limited by several factors. First, the cross-sectional study design used 
in all three studies prevents conclusions about causality and possible 
relationships between variables overtime. Second, the use of self-report 
measures to capture resilience, abuse, depressive symptoms, health-related 
quality of life, and HAART adherence may have been affected by social 
desirability constraints. Third, we were limited by participants’ retrospective 
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reports of abuse that may not have been accurate reflections of their 
experiences. Fourth, due to our somewhat small sample size, we may have been 
inadequately powered to detect significant direct relationships between some 
variables (e.g. abuse histories and depressive symptoms). Fifth, study 3 
assessed total stress hormone levels via overnight urine collection. However, 
researchers have begun to look at the reactivity of a person’s stress response 
system using repeated measures over the course of one day or more because 
this may yield useful information (Vedhara et al., 2006).  It is not clear whether 
total levels or levels and trajectories in response to specific stressors are more 
predictive of negative health outcomes. Future studies with larger samples and 
longitudinal designs are needed to increase our understanding of changes in 
resilience over time in relation to health outcomes in women with HIV and at risk 
for HIV.  
 An additional limitation of the study was that the CD-RISC resilience self-
report measure administered at one time point did not fully capture all of the 
components of resilience (e.g. personality traits, adaptive functioning) nor 
conceptualizations of resilience that have been posited in the literature, including 
thinking of resilience as an outcome, a process, or a trajectory of health 
functioning following a traumatic event (Bonanno, 2012). Given the diverse 
perspectives on what constitutes resilience and how it should be conceptualized, 
the ideal research approach may be a multi-measure and methods study that 
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includes personality attributes, coping strategies, and adaptive functioning 
outcomes overtime and that may be supplemented with other types of measures, 
including qualitative data. Short of this, the present study defined the specific 
approach taken to capture to resilience and was careful not to generalize about 
resilience beyond the specific assessment measure used.  
 Despite these limitations, there were several strengths of the existing 
studies. One, these studies utilized widely used and validated measures for 
assessing HAART medication adherence, depressive symptoms, health-related 
quality of life, undetectable viral load, coronary heart disease risk and urinary 
stress hormones.  Two, both qualitative methods (which were used to measure 
positive self-esteem) and quantitative methods (used to measure resilience) in 
assessing psychological factors in relation to health proved to be useful. Three, 
important sociodemographic variables (e.g. education, income and employment) 
were controlled in all analyses. Four, research staff members who have an 
established rapport with participants orally administered self-report measures 
(e.g. histories of abuse, HAART adherence, depressive symptoms, etc.), which 
may have increased the likelihood that women would respond honestly even 
when asked about histories of abuse. Five, steps were taken to limit recall bias in 
capturing HAART adherence (e.g. showing participants pictures of their current 
medications, or having participants bring their medication bottles). Six, although 
one cannot deduce causality from a cross-sectional design, most of the findings 
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in these studies were corroborated by existing literature, thereby giving credibility 
to the results. The novel findings extend our understanding of resilience and 
health outcomes among women with HIV and suggest additional areas for 
research and intervention efforts.  
 Implications of Findings and Future Directions 
 Taken together, the findings across all three studies that resilience and 
positive self-esteem relate to better health outcomes (a) highlight the power of 
resilience in directly relating to better health outcomes as well as in moderating 
the negative impact of abuse, (b) echo how important it is for providers and 
researchers to think about resilience in the context of caring for women infected 
with and at risk for HIV, and (c) strongly suggest that interventions that target 
resilience may improve the health outcomes of women with HIV.  Despite 
histories of abuse, some women score high on resilience, endorsing adaptive 
coping strategies and personal qualities, which buffer the potential untoward 
impact of abuse on their health outcomes. As such using the 10 item CD-RISC 
resilience scale (Campbell-Sills & Stein, 2007) as a screening measure might 
help health care providers to detect women who are at risk for depressive 
symptoms and HAART nonadherence and who might benefit from additional 
interventions, treatment and/or resources.  Furthermore, knowing which patients 
score high on resilience may highlight women who could potentially serve as 
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peer mentors to other women with HIV and/or as co-facilitators for HIV 
interventions.  
 The findings of these three studies also highlight the deleterious impacts 
of childhood and adulthood abuse on the health outcomes of women with HIV, 
and support the ongoing call for an end to violence against women and children 
at the societal level. Second, providers for women with and at risk for HIV may 
need to assess for abuse histories because women with abuse histories are 
especially vulnerable for depressive symptoms and medication nonadherence as 
shown in this study and previous literature (M. Cohen et al., 2000; M. H. Cohen 
et al., 2004; Machtinger, Haberer, et al., 2012).  
Possible Clinical Interventions 
 Findings across the three studies suggest that an intervention promoting 
resilience and positive self-esteem among women with and at risk for HIV 
(especially women with histories of abuse) may help women to achieve better 
health outcomes.  A resilience intervention for women with HIV or at risk HIV- 
women may consist of sessions on (1) psychoeducation about abuse and its 
impact on the health of women with HIV or at risk  (2) psychoeducation about 
different response patterns to stress/trauma  (3) resilient coping strategies that 
are especially relevant for women with HIV or women at risk (e.g. believing that 
you can take control and manage stressors in your life such as motherhood or 
HIV) (4) prominent themes for abuse survivors and women with HIV (e.g. self-
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esteem, stigma, self-blame) and (5) personal reflections by having women write 
about (a) evidence of their resilience based on their past and present 
experiences and (b) new strategies women will try to enhance their resilience 
and attain future goals.  The CD-RISC resilience measure might be used at 
baseline as an assessment tool, after each session of the intervention, and 
following treatment completion (Campbell-Sills & Stein, 2007).  
 There is evidence to support the feasibility of such an intervention.  For 
instance, among college students, Steinhardt and colleagues (2008) found that a 
resilience intervention was effective in increasing resilience and self-esteem 
scores and effective coping strategies and decreasing depressive symptoms, 
negative affect, and perceived stress. The four session intervention covered 
topics on (1) Transforming Stress Into Resilience, with resilience defined as an 
ability to return to levels of functioning prior to the stressor (2) Taking 
Responsibility which focused on participants’ power and responsibility in 
managing their stressors and life situations; and described responsibility as being 
closely linked to self-esteem (3) Focusing on Empowering Interpretations, which 
assisted participants in replacing negative/disempowering cognitions with 
positive/empowering cognitions using a cognitive-behavioral model and (4) 
Creating Meaningful Connections, which encouraged participants to maintain 
interpersonal relationships with supportive family and friends.  
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 In addition, some elements of Cognitive Processing Therapy and 
Prolonged Exposure treatments, two evidence-based treatments for survivors of 
trauma who suffer from PTSD, may be beneficial in an intervention for women 
with HIV and HIV- women with histories of abuse who score low on resilience 
and low on positive self-esteem (Foa, Rothbaum, Riggs, & Murdock, 1991; 
Resick, Nishith, Weaver, Astin, & Feuer, 2002). Cognitive Processing Therapy 
treats PTSD via psychoeducation about PTSD, exploration of the individual’s 
cognitions regarding the traumatic event, cognitive restructuring of maladaptive 
cognitions, and addressing themes such as trust, self-esteem and power (Resick 
et al., 2002). The individual is also asked to write about the traumatic event and 
include any emotions around themes such as self-blame.  They are then asked 
to read the narrative a few times at home and then to the therapist. Similar to 
CPT, Prolonged Exposure Therapy involves psychoeducation about PTSD and 
writing a narrative about the traumatic event, but differs in that PE includes the 
participant listening to and retelling the story repeatedly at home and in therapy 
as well as conducting in vivo exposures to stimuli that are reminiscent of the 
event (Foa et al., 1991).  While the proposed intervention for women with HIV or 
at risk women may not necessarily entail writing about a traumatic account, 
women may benefit from discussions about themes such as self-esteem and 
empowerment as well as writing and re-reading their personal reflections.  
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 In conclusion, findings across all three studies highlighted that resilience 
and positive self-esteem related to better health outcomes for women with HIV 
and sociodemographically matched at risk women. Resilience also buffered 
against the negative influence of abuse histories on depressive symptoms for 
women with and at risk for HIV and on medication adherence for women with 
HIV.  Future studies are needed to (a) further increase our understanding of 
resilience among women with HIV and women at risk for HIV infection and (b) 
develop interventions aimed at increasing resilience and positive self-esteem that 
could potentially improve the physical and mental health outcomes of this 
population.  
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Circulation, 105(11), 1354-1359.  
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CURRICULUM VITAE 
SANNISHA K. DALE 
725 Adams St #40 
Dorchester, MA 02122 
 (617) 501-1093 
sannishadale@gmail.com 
EDUCATION 
Boston University, 09/08-09/14                    Boston, MA 
Clinical Psychology Doctoral Program Ph.D. Candidate,  
GPA 4.00, Degree expected 2014 
Dissertation: “Resilience, Stress Hormones, and Health Outcomes in Women with HIV.”  
Advisor and first reader: Leslie R. Brody, Ph.D. 
Masters of Arts, Psychology, Class of 2010  
Harvard University Graduate School of Education, 09/04-06/05       Cambridge, MA 
Masters in Education, Human Development and Psychology  
Focus on Culture and Human Development, GPA 3.63, Class of 2005 
 
Boston College School of Arts and Sciences, 09/00-05/04        Chestnut Hill, MA 
Bachelor of Art, Psychology Major, GPA 3.71, Class of 2004 
 
GRANT AWARDS 
National Research Service Award, Award Number F31MH095510 from the National 
Institute of Mental Health, Project Title: Resilience, Norepinephrine, and Health 
Outcomes in Women with HIV, 09/11 – 08/13 
 
Diversity Research Supplement, Award Number U01AI034993-16S1 from the National 
Institute Of Allergy and Infectious Diseases under the American Recovery and 
Reinvestment Act of 2009, 09/09 – 08/11 
 
Travel Scholarship for Ethnic Minority Researchers and Community-Based 
Providers, 5th International Conference on HIV Treatment Adherence, 05/10	  
 
HONORS 
George F. and Jean W. Bemis Award, 2004, Awarded for service to the BC community 
M. Copithorne Scholarship, 2004, For exhibiting qualities of character and intelligence 
Boston College Order of the Cross and Crown, 2004-present, Leadership and merit 
Golden Keys National Honor Society, 2004-present, For high academic achievements 
Amanda Houston Fellowship, 2003, Travel fellowship to aid in research endeavor 
National Society of Collegiate Scholars, 2002-present, For academic merits 
Certificate of Leadership, 2003, Due to leadership on the BC campus 
Thea Bowman AHANA Scholar Award, 2000-2004, For academic achievements 
 
LEADERSHIP POSITIONS 
Publicity Manager, Colloquium Committee, Boston University, 07/09 – 08/10 
Student Chair, Minority Collective, Boston University, 08/09 – 08/10   
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Secretary, Student Government, Harvard Graduate School of Education, 09/04-05/05 
Co-Chair, African, Latino, Asian and Native American Alliance, HGSE, 09/04-05/05 
 
 
CONSULTATION EXPERIENCES 
American Psychological Association’s Behavioral and Social Science Volunteer 
(BSSV) Program  
Office on AIDs, Program funded by the Center for Disease Control 
Volunteer, 07/10-present 
• Trained and certified by APA to provide capacity building assistance to 
community based organizations implementing three HIV evidence based 
preventions/ interventions: SISTA (Sisters Informing Sisters about Topics on 
AIDS), 3MV (Many Men Many Voices) and Healthy Relationships 
• Help to diffuse evidence based HIV protocols through capacity building 
assistance to community based organizations  
 
American Psychological Association’s HOPE Program 
HIV Office for Psychology Education (HOPE) 
Program funded by the Center for Mental Health Services (CMHS) of the 
Substance Abuse and Mental Health Services Administration (SAMHSA) and the 
SAMHSA Minority AIDS Initiative Targeted Capacity Expansion (MAI-TCE) 12 
Cities Program 
Volunteer HIV/AIDS Mental Health Trainer, 05/12-present 
• Completed a training-of-trainer workshop on May 31–June 3, 2012 
• Trained on two curricula: Short-Term Evidence- Based Interventions for People 
Living With or at High Risk for HIV; and HIV Integrated Care: Integrating Mental 
Health, Substance Abuse Screening, Brief Assessment, and Referral to 
Treatment into HIV Prevention 
• Responsible for training at least 30 mental health professionals within 2 years  
• Belong to a national network of HOPE trainers who are psychologists, 
psychiatrists, and mental health clinicians who volunteer their time to provide 
their communities with the knowledge and skills necessary to better serve their 
HIV infected or at risk clients 
 
EXTERNAL PSYCHOLOGY TRAININGS  
American Psychological Association, Minority Fellowship Program  
Psychology Summer Institute (PSI), July 8 – 14, 2012         Washington, DC 
PSI provides educational, professional development and mentoring experiences to 
advanced doctoral students of psychology and psychologists who are in the early stage 
of their careers. 
• Received guidance and one-on-one mentoring on my dissertation project from 
Dr. Miriam Martinez, Chief of Clinical Strategy, St. Luke's Roosevelt Hospital 
Center, Department of Psychiatry and Behavioral Health 
• Participated in seminars on topics such as grant writing, publishing and specific 
areas of research or service delivery. Seminars were led by expert faculty such 
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as Dr. Norman Anderson (CEO, American Psychological Association), Dr. 
Nakamura (Acting Director, Center for Scientific Review, National Institute of 
Health), and Dr. Cheryl Boyce (Associate Director of Child and Adolescent 
Research, National Institute of Health). 
• Networked with representatives from federal funding agencies (e.g. NIH) and 
foundations 
 
PUBLICATIONS 
Brody, L.R., Dale, S., Kelso, G., Cruise, R., Weber, K., Watson, C.,Stokes, L., & Cohen, 
M. (in press). Gender roles and coping in relation to depression and quality of life in 
women with and at risk for HIV.  In S. Dworkin , P. Passano ,  & Gandhi (Eds). In 
Justice and In Health: A New Era in Women’s Health and Empowerment. California: 
UC Press. 
Henderson Daniel, J & Dale, S.K. (2013). Violence and Trauma. In L. Comas-Diaz, & B. 
Greene (eds). Psychological Health of Women of Color: Intersections, Challenges, 
and Opportunities. Westport, CT: Praeger.  
Dale, S.K. & Henderson Daniel, J. (2013). Talking about the Trayvon Martin Case in  
Psychology Training and Psychotherapy. Journal for Social Action in Counseling  
and Psychology, 5 (1), 37-49. 
Dale, S.K. & Henderson Daniel, J. (2011). Spirituality/Religion as a Healing Pathway for 
Survivors of SexualViolence. In: Thema Bryant-Davis (Ed.), Pathways to Healing: 
Empowerment for Survivors of Sexual Violence. Rowman & Littlefield Publishers. 
Tummala-Narra, P., Saleem, R., Dale, S., Claudius, M., Gomez, C., & Narain, N. (2011). 
Report on trafficking of women and girls, American Psychological Association 
Division 35 (Society for the Psychology of Women) Special Committee on Violence 
against Women and Girls, http://www.apadivisions.org/division-35/news-
events/trafficking-report.pdf 
Dale, S. (2006). My Home Away from Home. Ya Yuan - Yali Boarding Middle School Bi-
Monthly Magazine. Published: Changsha.  
Dale, S. (Ed.). (2005). Our Voices: Harvard University Graduate School of Education 
Annual ALANA Anthology. Fellows of Harvard: Cambridge. 
Dale, S. (2005). Who AM I- A Look at Racial, Cultural, and Personal Experiences that 
Have Impacted My Own Cultural Competency. Our Voices: Harvard University 
Graduate School of Education Annual ALANA Anthology. Fellows of Harvard: 
Cambridge.  
Dale, S. K., Kelso, G., Cruise, R.C, Watson, C., Cohen, M., Weber, K., Burke-Miller, J.,  
& Brody, L. R. (2012). Resilience among women with HIV and uninfected women: 
Impact of gender roles and socioeconomic factors. Manuscript revised and 
resubmitted for publication. 
Brody, L.R., Stokes, Dale, S. K., L., Kelso, G., Cruise, R., Weber, K., Burke-Miller,  
J., Cohen, M. (2012). Gender Roles in Women with HIV:  Relationship to Depressive 
Symptoms and Quality of Life. Manuscript revised and resubmitted for publication. 
Dale, S. K., Kelso, G., Cruise, R.C, Watson, C., Cohen, M., Weber, K., Burke-Miller, J.,  
& Brody, L. R. (2012). Resilience among women with HIV and uninfected women: 
Impact of gender roles and socioeconomic factors. Manuscript revised and 
resubmitted for publication. 
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Dale, S. K., Cruise, R.C., Kelso, G., Cohen, M., Weber, K., Burke-Miller, J., & Brody, L.  
R. Gender roles and abuse among women with HIV infection and women at risk for  
HIV. Manuscript in preparation. 
Dale, S.K., Cohen, M., Weber, K., Kelso, G., Cruise, R.C., & Brody, L. Abuse and 
Resilience in Women with HIV in Relation to HAART Medication Adherence and 
HIV Viral Load. Manuscript submitted for publication. 
Dale, S.K., Cohen, M., Kelso, G., Cruise, R.C., Weber, K., & Brody, L. Resilience, 
Childhood Sexual Abuse, Depressive symptoms, and Health-Related Quality of Life 
in Women with and at Risk for HIV. Manuscript submitted for publication. 
Kelso, G., Cohen, M., Dale, S. K., Cruise, R. C., Weber, K., & Brody, L. Critical  
consciousness, racial and gender discrimination, and HIV disease markers in  
African-American women with HIV. Manuscript submitted for publication. 
Kelso, G., Weber, K., Dale, S. K., Cruise, R. C., Cohen, M., & Brody, L. Social and  
health correlates of critical consciousness in African-American women with and at 
risk for HIV. Manuscript submitted for publication. 
Kelso, G., Cohen, M., Weber, K., Dale, S. K., Cruise, R. C., & Brody, L. Incarceration,  
critical consciousness, depressive symptoms, and HIV in Black women. Manuscript  
submitted for publication. 
 
PRESENTATIONS 
Dale, S.K., Cohen, M., Weber, K., Kelso, G., Cruise, R.C., & Brody, L. (2013).  
Resilience in Women with HIV: Relationships with Abuse History, Medication 
Adherence and Viral Load [Oral presentation]. Abstract accepted for presentation at 
the 8th International Conference on HIV Treatment Adherence, Miami, Florida.  
Dale, S.K., Bogart, L.M., Wagner, G.J., Galvan, F.H., & Klein, D.J. (2013). Medical  
Mistrust Predicts Lower Longitudinal Medication Adherence Among African 
American Men [Oral presentation]. Abstract accepted for presentation at the 8th 
International Conference on HIV Treatment Adherence, Miami, Florida.  
Dale, S.K., Franklin, M., Kelso, G., Cruise, R., Burke, M., Weber, K., Cohen, M. & Brody, 
L. (2012). Childhood Sexual Abuse, Traditional Gender Roles, and Coronary Heart 
Disease Risk Among Women with HIV. 2nd International Workshop on HIV & 
Women. Bethesda, Maryland. 
http://www.natap.org/2012/HIVwomen/HIVwomen_11.htm 
Dale, S.K., M., Kelso, G., Cruise, R., Burke, M., Weber, K., Cohen, M. & Brody, L.  
(2012). Among Women with  
HIV, Interaction between Childhood Sexual Abuse and Denial Predicts Medication 
Adherence and Quality of Life. Poster presented at the 7th International Conference 
on HIV Treatment Adherence, Miami, Florida.  
Dale, S.K. (2012). Perspective of a National Research Service Award (F31) recipient  
[Oral Presentation]. In A.M.Breland-Noble and C.A. Boyce (Co-chairs). Racially 
Diverse Investigators and Research Careers Psychologists Respond to the 2011 
Science Article. Symposium held at the 120th Annual APA Convention, Orlando, 
Florida. 
Dale, S.K., M., Kelso, G., Cruise, R., Burke, M., Weber, K., Cohen, M. & Brody, L.  
(2012). Traditional gender roles and disempowering coping strategies among 
women with HIV predict low treatment adherence and poor health outcomes [Oral 
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presentation]. The Public Health Implications of Global Violence on Women and 
Youth. Abstract presented at the 140th APHA Annual Meeting in San Francisco, 
California. 
Dale, S.K. (2012). Mental health among adolescent females. Workshop presentation at  
the NAASC 6th Annual Blueprint Conference for Middle & High School Girls,  
Boston, Massachusetts. 
Cruise, R., Kelso, G., Dale, S.K., Weber, K., Cohen, M. & Brody, L. (2012). Substance  
abuse and gender roles in women with and at risk for HIV. Poster presented at the  
120th Annual APA Convention, Orlando, Florida. 
Kelso, G., Dale, S.K., Cruise, R. Weber, K., Cohen, M. & Brody, L. (2012). Depressive  
Symptoms, Self-Silencing, Critical Consciousness and HIV in African American 
Women. Poster presented at the Association of Psychological Sciences Annual 
Convention, Chicago, Illinois.  
Kelso, G., Cruise, R., Dale, S.K., Weber, K., Cohen, M. & Brody, L. (2012). Critical 
consciousness, perceived racial discrimination, and gender discrimination in relation 
to demographics and HIV status in African American women [Oral presentation]. 
Abstract presented at the XIX International AIDS Conference, Washington, DC.  
Kelso, G., Dale, S.K., Cruise, R. C., Weber, K., Cohen, M., & Brody, L. (2012). Critical 
consciousness and discrimination stress in relation to CD4 cell count and viral load 
in African American women with HIV [Oral Presentation]. Abstract presented at the 
12th Annual Diversity Challenge, Boston College, Boston, MA. 
Kelso, G., Dale, S., Cruise, R., Weber, K., Cohen, M., & Brody, L.(2012). Discrimination-
related stress, critical consciousness, and depressive symptoms in HIV-infected 
African American women. Poster presented at the CFAR Joint Symposium on HIV 
Research in Women, Providence, RI. 
Salimian, P., Bark, J., David, J., Cruise, R., Dale, S.K., M., Kelso, G., Weber, K., Cohen, 
M. & Brody, L. (2012). How do coping strategies affect HIV disclosure? Poster 
presented at the 140th APHA Annual Meeting in San Francisco, California. 
Dale, S. K., Kelso, G., Watson, C., Weber, K., David, J., Linh, V., Cohen, M., & Brody, L. 
R. (2011).Trauma History, Resilience and Gender Roles among Women with HIV or 
at risk for HIV. Poster presented at a Division 35 round table at the 119th Annual 
APA Convention.  
Dale, S. K., Brody, L. R., Kelso, G. W., Stokes, L., Weber, K., Hoffman, A., Chen, B., 
Patena, J., Ramones, S., & Cohen, M. (2011). Gender Roles and Knowledge of 
Partner’s HIV Status among Women With or At Risk for HIV. Poster presented at 
the Women's Health 2011: The 19th Annual Congress. 
Kelso, G., Dale, S. K., Watson, C., Weber, K., Lee, Y., Piepenburg, A., Gizzi, A.,  
Friedman, J. Byun, J., Cohen, M., & Brody, L. R. (2011). Relationships between  
responsibility placement in autobiographical narratives and health in HIV-positive 
women with abuse histories. Poster presented at the 119th American Psychological 
Association Convention, Washington, D.C. 
Dale, S. K., Brody, L. R., Kelso, G. W., Stokes, L., Cohen, M., Weber, K., Lefkowitz, A.,  
Spencer, T.A., Lombardo, L., & Yan, D. (2010). Resilience and Coronary Heart 
Disease Risk in Women with or at risk for HIV. Poster presented at the Women's 
Health 2010: The 18th Annual Congress.    
Dale, S. K., Brody, L. R., Cohen, M., Kelso, G., Weber, K., Piepenburg, A., Hoffman, A.,  
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Lee, Y., Chen, B. & Stokes, L. (2010). Gender Roles, Resilience, and Coronary 
Heart Disease Risk Among Women. Poster presented at the 118th Annual APA 
Convention.  
Brody, L. R., Dale, S. K., Kelso, G. W., Stokes, L., Jeong, H. K., Weber, K., & Cohen, M.  
(2010). Gender roles, HIV disclosure, and medication adherence among women 
with HIV. Poster presented at the 5th International Conference on HIV Treatment 
Adherence.  
Ghidei, L., Dale, S. K., Brody, L. R., Cohen, M. & Weber, K. (2010). The Expression of 
Words Related to Race, Gender, and Discrimination in Autobiographical Narratives 
in Relation to Coronary Heart Disease Risk in Women with or at Risk for HIV. 
Poster presented at the 13th Annual Boston University UROP Symposium. 
Kelso, G. W., Stokes, L., Dale, S. K., Kim, J. H., Lombardo, L., Cohen, M., Weber, K. &  
Brody, L.R. (2010). Self-Silencing and Quality of Life in Women as a Function of HIV  
status. Poster presented at the Association of Psychological Sciences Annual 
Convention 
 
RESEARCH EXPERIENCE 
Boston University Emotion, Gender, Culture and Health Laboratory  Boston, MA 
Graduate Research Assistant for Dr. Leslie Brody, 09/08 to 05/13    
 
The lab is a co-investigative site for NIH grant # U01-AI-34994, Chicago site of the 
Women’s Interagency HIV Study (WIHS); PI: Mardge Cohen, co-I: Leslie Brody. WIHS is 
a multisite longitudinal observational study that began in 1994 and is the largest U.S. 
cohort to date of HIV-seropositive women with a comparison cohort of seronegative 
women. The current project seeks to provide a clearer understanding of factors that may 
contribute to the health outcomes of black and other ethnic minority women with and at 
risk for HIV infection, many of whom have histories of trauma, including violence and 
abuse, by exploring three interrelated processes: coping skills, self-silencing, and 
unmitigated communion. The study aims to: (1) explore the relationship between coping 
styles (including self-silencing, and unmitigated communion) and HIV status and trauma 
history and (2) To explore the role of coping, self-silencing, and unmitigated communion 
in moderating the relationship between trauma history and health outcomes in HIV+ 
women, including HIV disease progression, medication adherence and other health 
outcomes. My duties include assisting in the development of procedures, themes and 
manuals for coding autobiographical narratives; utilizing SPSS to organize and analyze 
data from self-report measures as well as evaluate the psychometric properties of 
instruments; and conducting exploratory analysis on the relationship between trauma, 
coping, resilience and health outcomes. 
 
Harvard Children’s Hospital and Fenway Health           Boston, MA 
HIV Research Collaborator with Dr. Laura Bogart, 06/12 to present  
 
The current project is a pilot intervention on addressing discrimination and mistrust 
among African American MSM who are HIV seropositive. The two major aims are to 1) 
develop an intervention to address mistrust and improve coping responses to 
discrimination by working with community stakeholders and conducting qualitative semi-
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structured interviews with Black MSM and 2) explore pilot intervention effects on 
mistrust, coping, mental health, antiretroviral treatment adherence, and engagement in 
care. My duties include consulting with the research team about project design and 
development and conducting qualitative interviews with Black MSM. In addition, I am 
drafting data analysis plans and exploring findings for potential manuscripts using data 
previously collected by Dr. Bogart on HIV treatment attitudes and behaviors among 
Black and Latino men with HIV. 
 
Psychology Department of Boston College           Chestnut Hill, MA 
Senior Thesis under the supervision of Dr. Gilda Morelli, 09/02-5/04 
• Initiated an independent research project on the “Future Expectations of 
Adolescents in Kingston, Jamaica” 
• Received Institutional Review Board approval, conducted interviews and 
administered surveys in Jamaica  
• Transcribed interviews, organized themes, analyzed data and composed a report 
(50pgs)  
 
 
CLINICAL EXPERIENCE 
Brown University Medical School/ Bradley Hasbro Children's Research 
Center/Rhode Island Training School 
Practicum Trainee, 10 hours/week, 09/12 to 05/13  Providence, MA 
• Lead two substance abuse psychotherapy groups for adolescent male juvenile 
delinquents aimed at teaching cognitive behavioral and emotion regulation skills 
to use in problem solving 
• Lead a psychotherapy group for adolescent female juvenile delinquents using the 
curriculum from VOICES – A program of self discovery and empowerment for 
girls  
• Attend weekly individual supervision, groups supervisions with detention and 
community providers, and client case review meetings  
 
PTSD Program in the Behavioral Science Division of the National Center for PTSD 
VA Boston Healthcare System, Jamaica Plain Campus   Boston, MA 
Practicum Trainee, 16 hours/week, 09/12 to 06/13 
Practicum students working in the PTSD clinic of the Behavioral Science Division have 
the opportunity to acquire both assessment and treatment experience working with 
veterans diagnosed with PTSD and other trauma-linked disorders. Trainees learn state-
of-the-art assessment procedures, are trained in semi-structured interviewing for PTSD, 
and evidence-based treatments for PTSD (e.g., cognitive processing therapy, prolonged 
exposure).  
• Provide individual psychotherapy to 5 adult veterans with PTSD and other 
trauma-linked disorders 
• Co-facilitate an introduction to PTSD group and a processing group for WWII 
veterans  
• On a weekly basis receive 2.5 hours of individual supervision from licensed 
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psychologists 
• Participate in a 2 day training on Cognitive Processing Therapy (CPT) led by Dr. 
Patricia Resick 
 
Boston University Center for Anxiety and Related Disorders (CARD)  Boston, MA 
Supervisor Trainee in Adult CARD, 5 hours/week, 09/11 to 08/12 
• Supervise adult therapy provided by a second year PhD student via weekly 
supervision sessions, session audio reviews and live observations 
Practicum Trainee in Child CARD,15 hours/week, 09/11 to 08/12 
• Conduct child psychological assessments for treatment utilizing the Anxiety 
Diagnostic Interview Schedule for DSM-IV and other relevant questionnaires  
• Provide individual child cognitive behavioral therapy to treat anxiety and related 
disorders 
• Supervised by a licensed psychologist who specializes in cognitive behavioral 
therapy for child and adolescents  
 
Department of Veterans Affairs-Edith Nourse Rogers Memorial VA Medical Center  
Center for Psychotherapeutic Change (CPC) 
Practicum Trainee, 24 hours/week, 09/10 to 05/11    Bedford, MA 
CPC provides a range of short-term and longer-term individual and couples 
psychotherapy, incorporating dynamic, cognitive, behavioral, experiential, and 
humanistic/transpersonal perspectives in an integrative approach to treatment.  The 
PTSD & Returning Veterans Program, in cooperation with the CPC, provides individual 
and group psychotherapy services for veterans with PTSD using a phase treatment 
model that includes assessment, psychoeducation, skills training, trauma processing 
and relapse prevention. Through this collaboration the CPC also offers training in 
evidence-based treatments including CBT for PTSD, Cognitive Processing Therapy, and 
Seeking Safety. Practicum trainees can also participate in several therapy groups for 
CBT, Mindfulness and PTSD.  
• Provided individual psychotherapy to 10 adult veterans (75% with PTSD 
diagnoses) 
• Co-facilitated a Beyond Trauma psychotherapy group (for female veterans) and 
an Anger Management group   
• Conducted 2 hour intakes (interview and administration of relevant scales) on a 
bi-weekly basis 
• On a weekly basis received 2 hours of individual supervision from licensed 
psychologists and 1 hour of group supervision from post-doctoral fellows and 
peers 
• Attended a weekly mindfulness training seminar 
• Participated in a 3 day training on Prolonged Exposure Therapy (PE) led by 
trained PE consultants 
 
Boston University Center for Anxiety and Related Disorders  Boston, MA 
Psychological Services Center 
Practicum Trainee, 15 hours/week, 08/09 to 08/10 
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• Conducted adult psychological assessments for treatment utilizing the Mini-
Anxiety Diagnostic Interview Schedule for DSM-IV and other relevant 
questionnaires (e.g. Beck Depression Inventory, PTSD Questionnaire) 
• Performed neuropsychological assessments with instruments such as the WAIS 
and Woodcock Johnson 
• Provided individual cognitive behavioral therapy to treat mood and anxiety 
disorders 
• Supervised by a licensed psychologist who specializes in cognitive behavioral 
therapy 
 
TEACHING EXPERIENCE/ EMPLOYMENT 
Boston University Metropolitan College     Boston, MA 
Clinical Psychology (PS 273), Instructor, 09/11 to 12/11, 09/12 to 12/12  
• Provide an overview and general understanding of the field of Clinical 
Psychology 
• First half of this course covers topics such as the evolution of clinical psychology, 
controversies, ethics, diagnosis and assessment 
• Second half of the course survey different schools of psychotherapy (e.g. 
cognitive behavioral therapy and psychodynamic); and review a few areas of 
concentration in clinical psychology (e.g. health psychology).  
Creativity in Psychology (PS 222), Instructor, 07/11 to 08/11, 05/13 to 06/13  
• Covered the psychological and social contexts under which creativity and its 
products are able to flourish (or perish) and reviewed research studies on the 
personality characteristics of creative individuals 
 Abnormal Psychology, Instructor (PS 371), 01/10 to 05/11, 01/12 to 05/12, 01/13 to05/13  
• Assisted undergraduate students in developing an understanding of abnormal 
behavior and psychological diagnoses through lectures, movies, presentations, 
and discussions of information presented in readings  
 
MEMBERSHIPS 
American Psychological Association of Graduate Students  
Division 12 - Society of Clinical Psychology, American Psychological Association  
Division 35 - Society for the Psychology of Women, American Psychological Association  
Division 45 – Society for Psychological Study of Ethnic Minority Issues, American 
Psychological Association  
Division 56 - Trauma Psychology, American Psychological Association 
 
